GNF SymAtlas + NCI-60 cancer cell lines, human (Su, 2004; Ross, 2000)
Gene Symbol | Gene ID | Gene Info |
---|---|---|
HIC1
|
ENSG00000177374.8 | HIC ZBTB transcriptional repressor 1 |
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
HIC1 | hg19_v2_chr17_+_1959369_1959604, hg19_v2_chr17_+_1958388_1958404 | 0.40 | 1.0e-09 | Click! |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr1_+_6845384 | 77.19 |
ENST00000303635.7
|
CAMTA1
|
calmodulin binding transcription activator 1 |
chr15_+_68871308 | 47.32 |
ENST00000261861.5
|
CORO2B
|
coronin, actin binding protein, 2B |
chr16_+_58497567 | 43.51 |
ENST00000258187.5
|
NDRG4
|
NDRG family member 4 |
chr19_+_709101 | 43.51 |
ENST00000338448.5
|
PALM
|
paralemmin |
chr19_+_708910 | 42.23 |
ENST00000264560.7
|
PALM
|
paralemmin |
chr16_+_1662326 | 41.01 |
ENST00000397412.3
|
CRAMP1L
|
Crm, cramped-like (Drosophila) |
chr18_-_74844727 | 40.67 |
ENST00000355994.2
ENST00000579129.1 |
MBP
|
myelin basic protein |
chr9_-_101471479 | 40.29 |
ENST00000259455.2
|
GABBR2
|
gamma-aminobutyric acid (GABA) B receptor, 2 |
chr9_+_137979506 | 39.96 |
ENST00000539529.1
ENST00000392991.4 ENST00000371793.3 |
OLFM1
|
olfactomedin 1 |
chr20_+_44034804 | 39.96 |
ENST00000357275.2
ENST00000372720.3 |
DBNDD2
|
dysbindin (dystrobrevin binding protein 1) domain containing 2 |
chr4_-_109684120 | 39.96 |
ENST00000512646.1
ENST00000411864.2 ENST00000296486.3 ENST00000510706.1 |
ETNPPL
|
ethanolamine-phosphate phospho-lyase |
chr19_+_35521572 | 36.67 |
ENST00000262631.5
|
SCN1B
|
sodium channel, voltage-gated, type I, beta subunit |
chr2_-_224903995 | 36.07 |
ENST00000409304.1
ENST00000454956.1 ENST00000258405.4 |
SERPINE2
|
serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 2 |
chr16_+_226658 | 35.77 |
ENST00000320868.5
ENST00000397797.1 |
HBA1
|
hemoglobin, alpha 1 |
chr19_+_35521616 | 35.23 |
ENST00000595652.1
|
SCN1B
|
sodium channel, voltage-gated, type I, beta subunit |
chrX_+_38420783 | 34.83 |
ENST00000422612.2
ENST00000286824.6 ENST00000545599.1 |
TSPAN7
|
tetraspanin 7 |
chr6_-_84419101 | 34.37 |
ENST00000520302.1
ENST00000520213.1 ENST00000439399.2 ENST00000428679.2 ENST00000437520.1 |
SNAP91
|
synaptosomal-associated protein, 91kDa |
chr12_-_45270151 | 32.53 |
ENST00000429094.2
|
NELL2
|
NEL-like 2 (chicken) |
chr7_-_44365020 | 32.37 |
ENST00000395747.2
ENST00000347193.4 ENST00000346990.4 ENST00000258682.6 ENST00000353625.4 ENST00000421607.1 ENST00000424197.1 ENST00000502837.2 ENST00000350811.3 ENST00000395749.2 |
CAMK2B
|
calcium/calmodulin-dependent protein kinase II beta |
chr17_-_15903002 | 31.94 |
ENST00000399277.1
|
ZSWIM7
|
zinc finger, SWIM-type containing 7 |
chr6_-_84418841 | 31.90 |
ENST00000369694.2
ENST00000195649.6 |
SNAP91
|
synaptosomal-associated protein, 91kDa |
chr11_-_2160611 | 31.86 |
ENST00000416167.2
|
IGF2
|
insulin-like growth factor 2 (somatomedin A) |
chr12_-_45270077 | 31.75 |
ENST00000551601.1
ENST00000549027.1 ENST00000452445.2 |
NELL2
|
NEL-like 2 (chicken) |
chrX_+_38420623 | 31.70 |
ENST00000378482.2
|
TSPAN7
|
tetraspanin 7 |
chr18_+_77439775 | 31.31 |
ENST00000299543.7
ENST00000075430.7 |
CTDP1
|
CTD (carboxy-terminal domain, RNA polymerase II, polypeptide A) phosphatase, subunit 1 |
chr10_+_121485588 | 31.04 |
ENST00000361976.2
ENST00000369083.3 |
INPP5F
|
inositol polyphosphate-5-phosphatase F |
chr12_+_121078355 | 29.84 |
ENST00000316803.3
|
CABP1
|
calcium binding protein 1 |
chr10_+_124221036 | 29.56 |
ENST00000368984.3
|
HTRA1
|
HtrA serine peptidase 1 |
chr11_-_12030905 | 28.85 |
ENST00000326932.4
|
DKK3
|
dickkopf WNT signaling pathway inhibitor 3 |
chr16_-_1661988 | 28.76 |
ENST00000426508.2
|
IFT140
|
intraflagellar transport 140 homolog (Chlamydomonas) |
chr20_+_44034676 | 28.62 |
ENST00000372723.3
ENST00000372722.3 |
DBNDD2
|
dysbindin (dystrobrevin binding protein 1) domain containing 2 |
chr8_-_120685608 | 28.50 |
ENST00000427067.2
|
ENPP2
|
ectonucleotide pyrophosphatase/phosphodiesterase 2 |
chr5_+_134240588 | 28.14 |
ENST00000254908.6
|
PCBD2
|
pterin-4 alpha-carbinolamine dehydratase/dimerization cofactor of hepatocyte nuclear factor 1 alpha (TCF1) 2 |
chr6_-_46459099 | 27.97 |
ENST00000371374.1
|
RCAN2
|
regulator of calcineurin 2 |
chr13_+_42031679 | 27.78 |
ENST00000379359.3
|
RGCC
|
regulator of cell cycle |
chr9_+_130374537 | 27.64 |
ENST00000373302.3
ENST00000373299.1 |
STXBP1
|
syntaxin binding protein 1 |
chr15_+_80696666 | 27.13 |
ENST00000303329.4
|
ARNT2
|
aryl-hydrocarbon receptor nuclear translocator 2 |
chr11_+_70244510 | 25.13 |
ENST00000346329.3
ENST00000301843.8 ENST00000376561.3 |
CTTN
|
cortactin |
chr11_-_777467 | 24.81 |
ENST00000397472.2
ENST00000524550.1 ENST00000319863.8 ENST00000526325.1 ENST00000442059.2 |
PDDC1
|
Parkinson disease 7 domain containing 1 |
chr15_+_68871569 | 24.61 |
ENST00000566799.1
|
CORO2B
|
coronin, actin binding protein, 2B |
chr2_+_241938255 | 24.46 |
ENST00000401884.1
ENST00000405547.3 ENST00000310397.8 ENST00000342631.6 |
SNED1
|
sushi, nidogen and EGF-like domains 1 |
chr2_-_99552620 | 23.85 |
ENST00000428096.1
ENST00000397899.2 ENST00000420294.1 |
KIAA1211L
|
KIAA1211-like |
chr8_+_104152922 | 23.67 |
ENST00000309982.5
ENST00000438105.2 ENST00000297574.6 |
BAALC
|
brain and acute leukemia, cytoplasmic |
chr14_+_102027688 | 23.43 |
ENST00000510508.4
ENST00000359323.3 |
DIO3
|
deiodinase, iodothyronine, type III |
chr7_+_45613958 | 23.32 |
ENST00000297323.7
|
ADCY1
|
adenylate cyclase 1 (brain) |
chr6_-_109330702 | 22.97 |
ENST00000356644.7
|
SESN1
|
sestrin 1 |
chr2_-_38604398 | 22.43 |
ENST00000443098.1
ENST00000449130.1 ENST00000378954.4 ENST00000539122.1 ENST00000419554.2 ENST00000451483.1 ENST00000406122.1 |
ATL2
|
atlastin GTPase 2 |
chr17_-_15165854 | 22.31 |
ENST00000395936.1
ENST00000395938.2 |
PMP22
|
peripheral myelin protein 22 |
chr1_+_169075554 | 22.24 |
ENST00000367815.4
|
ATP1B1
|
ATPase, Na+/K+ transporting, beta 1 polypeptide |
chr20_+_44035200 | 22.06 |
ENST00000372717.1
ENST00000360981.4 |
DBNDD2
|
dysbindin (dystrobrevin binding protein 1) domain containing 2 |
chr6_+_107811162 | 22.05 |
ENST00000317357.5
|
SOBP
|
sine oculis binding protein homolog (Drosophila) |
chr1_+_10270863 | 22.04 |
ENST00000377093.4
ENST00000263934.6 |
KIF1B
|
kinesin family member 1B |
chr12_+_53440753 | 21.82 |
ENST00000379902.3
|
TENC1
|
tensin like C1 domain containing phosphatase (tensin 2) |
chr4_-_57522598 | 21.36 |
ENST00000553379.2
|
HOPX
|
HOP homeobox |
chr3_+_53528659 | 21.30 |
ENST00000350061.5
|
CACNA1D
|
calcium channel, voltage-dependent, L type, alpha 1D subunit |
chr8_-_101571964 | 21.22 |
ENST00000520552.1
ENST00000521345.1 ENST00000523000.1 ENST00000335659.3 ENST00000358990.3 ENST00000519597.1 |
ANKRD46
|
ankyrin repeat domain 46 |
chr6_+_43543864 | 21.19 |
ENST00000372236.4
ENST00000535400.1 |
POLH
|
polymerase (DNA directed), eta |
chr4_-_57522673 | 21.06 |
ENST00000381255.3
ENST00000317745.7 ENST00000555760.2 ENST00000556614.2 |
HOPX
|
HOP homeobox |
chr22_+_33197683 | 21.04 |
ENST00000266085.6
|
TIMP3
|
TIMP metallopeptidase inhibitor 3 |
chr17_+_30813576 | 20.93 |
ENST00000313401.3
|
CDK5R1
|
cyclin-dependent kinase 5, regulatory subunit 1 (p35) |
chr20_-_50384864 | 20.80 |
ENST00000311637.5
ENST00000402822.1 |
ATP9A
|
ATPase, class II, type 9A |
chr20_-_50385138 | 20.74 |
ENST00000338821.5
|
ATP9A
|
ATPase, class II, type 9A |
chr8_-_101571933 | 20.56 |
ENST00000520311.1
|
ANKRD46
|
ankyrin repeat domain 46 |
chrX_-_2418596 | 20.55 |
ENST00000381218.3
|
ZBED1
|
zinc finger, BED-type containing 1 |
chr1_-_241520525 | 20.47 |
ENST00000366565.1
|
RGS7
|
regulator of G-protein signaling 7 |
chr7_+_4721885 | 20.46 |
ENST00000328914.4
|
FOXK1
|
forkhead box K1 |
chr9_+_17579084 | 20.29 |
ENST00000380607.4
|
SH3GL2
|
SH3-domain GRB2-like 2 |
chr2_+_46524537 | 20.21 |
ENST00000263734.3
|
EPAS1
|
endothelial PAS domain protein 1 |
chr6_-_56819385 | 20.19 |
ENST00000370754.5
ENST00000449297.2 |
DST
|
dystonin |
chr10_-_81205373 | 20.09 |
ENST00000372336.3
|
ZCCHC24
|
zinc finger, CCHC domain containing 24 |
chr9_+_137967366 | 20.05 |
ENST00000252854.4
|
OLFM1
|
olfactomedin 1 |
chr17_-_74236382 | 20.02 |
ENST00000592271.1
ENST00000319945.6 ENST00000269391.6 |
RNF157
|
ring finger protein 157 |
chr22_-_21213029 | 19.96 |
ENST00000572273.1
ENST00000255882.6 |
PI4KA
|
phosphatidylinositol 4-kinase, catalytic, alpha |
chr11_-_66336060 | 19.81 |
ENST00000310325.5
|
CTSF
|
cathepsin F |
chr16_+_84002234 | 19.81 |
ENST00000305202.4
|
NECAB2
|
N-terminal EF-hand calcium binding protein 2 |
chr2_-_175870085 | 19.78 |
ENST00000409156.3
|
CHN1
|
chimerin 1 |
chr10_+_126150369 | 19.66 |
ENST00000392757.4
ENST00000368842.5 ENST00000368839.1 |
LHPP
|
phospholysine phosphohistidine inorganic pyrophosphate phosphatase |
chr19_-_460996 | 19.62 |
ENST00000264554.6
|
SHC2
|
SHC (Src homology 2 domain containing) transforming protein 2 |
chr17_-_79139817 | 19.34 |
ENST00000326724.4
|
AATK
|
apoptosis-associated tyrosine kinase |
chr4_-_57522470 | 19.33 |
ENST00000503639.3
|
HOPX
|
HOP homeobox |
chr19_-_19006890 | 19.32 |
ENST00000247005.6
|
GDF1
|
growth differentiation factor 1 |
chr8_+_1922024 | 19.22 |
ENST00000320248.3
|
KBTBD11
|
kelch repeat and BTB (POZ) domain containing 11 |
chr19_-_42746714 | 19.16 |
ENST00000222330.3
|
GSK3A
|
glycogen synthase kinase 3 alpha |
chr22_-_45559642 | 19.05 |
ENST00000426282.2
|
CTA-217C2.1
|
CTA-217C2.1 |
chr2_+_20646824 | 18.86 |
ENST00000272233.4
|
RHOB
|
ras homolog family member B |
chr6_-_84418860 | 18.84 |
ENST00000521743.1
|
SNAP91
|
synaptosomal-associated protein, 91kDa |
chr16_+_66914264 | 18.81 |
ENST00000311765.2
ENST00000568869.1 ENST00000561704.1 ENST00000568398.1 ENST00000566776.1 |
PDP2
|
pyruvate dehyrogenase phosphatase catalytic subunit 2 |
chr19_-_49944806 | 18.74 |
ENST00000221485.3
|
SLC17A7
|
solute carrier family 17 (vesicular glutamate transporter), member 7 |
chr17_+_38083977 | 18.60 |
ENST00000578802.1
ENST00000578478.1 ENST00000582263.1 |
RP11-387H17.4
|
RP11-387H17.4 |
chr7_-_99756293 | 18.54 |
ENST00000316937.3
ENST00000456769.1 |
C7orf43
|
chromosome 7 open reading frame 43 |
chr3_+_32147997 | 18.48 |
ENST00000282541.5
|
GPD1L
|
glycerol-3-phosphate dehydrogenase 1-like |
chr4_+_3768075 | 18.45 |
ENST00000509482.1
ENST00000330055.5 |
ADRA2C
|
adrenoceptor alpha 2C |
chr17_-_80656528 | 18.37 |
ENST00000538809.2
ENST00000269347.6 ENST00000571995.1 |
RAB40B
|
RAB40B, member RAS oncogene family |
chr2_-_175869936 | 18.35 |
ENST00000409900.3
|
CHN1
|
chimerin 1 |
chr4_+_1795012 | 18.18 |
ENST00000481110.2
ENST00000340107.4 ENST00000440486.2 ENST00000412135.2 |
FGFR3
|
fibroblast growth factor receptor 3 |
chr19_+_18718214 | 17.77 |
ENST00000600490.1
|
TMEM59L
|
transmembrane protein 59-like |
chr3_+_49027308 | 17.76 |
ENST00000383729.4
ENST00000343546.4 |
P4HTM
|
prolyl 4-hydroxylase, transmembrane (endoplasmic reticulum) |
chr5_+_76506706 | 17.60 |
ENST00000340978.3
ENST00000346042.3 ENST00000264917.5 ENST00000342343.4 ENST00000333194.4 |
PDE8B
|
phosphodiesterase 8B |
chrX_+_110187513 | 17.56 |
ENST00000446737.1
ENST00000425146.1 |
PAK3
|
p21 protein (Cdc42/Rac)-activated kinase 3 |
chr12_-_124457371 | 17.49 |
ENST00000238156.3
ENST00000545037.1 |
CCDC92
|
coiled-coil domain containing 92 |
chr21_-_34100244 | 17.47 |
ENST00000382491.3
ENST00000357345.3 ENST00000429236.1 |
SYNJ1
|
synaptojanin 1 |
chr9_-_139922631 | 17.46 |
ENST00000341511.6
|
ABCA2
|
ATP-binding cassette, sub-family A (ABC1), member 2 |
chr4_+_2965307 | 17.41 |
ENST00000398051.4
ENST00000503518.2 ENST00000398052.4 ENST00000345167.6 ENST00000504933.1 ENST00000442472.2 |
GRK4
|
G protein-coupled receptor kinase 4 |
chr7_-_22396533 | 17.38 |
ENST00000344041.6
|
RAPGEF5
|
Rap guanine nucleotide exchange factor (GEF) 5 |
chr3_-_149688502 | 17.17 |
ENST00000481767.1
ENST00000475518.1 |
PFN2
|
profilin 2 |
chr1_-_6240183 | 17.14 |
ENST00000262450.3
ENST00000378021.1 |
CHD5
|
chromodomain helicase DNA binding protein 5 |
chr7_-_124405681 | 17.13 |
ENST00000303921.2
|
GPR37
|
G protein-coupled receptor 37 (endothelin receptor type B-like) |
chr22_-_39239987 | 17.05 |
ENST00000333039.2
|
NPTXR
|
neuronal pentraxin receptor |
chr6_+_147830063 | 16.93 |
ENST00000367474.1
|
SAMD5
|
sterile alpha motif domain containing 5 |
chr12_-_53574376 | 16.90 |
ENST00000267085.4
ENST00000379850.3 ENST00000379846.1 ENST00000424990.1 |
CSAD
|
cysteine sulfinic acid decarboxylase |
chr11_-_108369101 | 16.90 |
ENST00000323468.5
|
KDELC2
|
KDEL (Lys-Asp-Glu-Leu) containing 2 |
chr14_+_65171099 | 16.87 |
ENST00000247226.7
|
PLEKHG3
|
pleckstrin homology domain containing, family G (with RhoGef domain) member 3 |
chr6_+_43543942 | 16.87 |
ENST00000372226.1
ENST00000443535.1 |
POLH
|
polymerase (DNA directed), eta |
chr15_-_71146480 | 16.87 |
ENST00000299213.8
|
LARP6
|
La ribonucleoprotein domain family, member 6 |
chr2_+_220379052 | 16.78 |
ENST00000347842.3
ENST00000358078.4 |
ASIC4
|
acid-sensing (proton-gated) ion channel family member 4 |
chr6_+_31865552 | 16.68 |
ENST00000469372.1
ENST00000497706.1 |
C2
|
complement component 2 |
chr2_-_86564776 | 16.66 |
ENST00000165698.5
ENST00000541910.1 ENST00000535845.1 |
REEP1
|
receptor accessory protein 1 |
chr1_+_184356188 | 16.63 |
ENST00000235307.6
|
C1orf21
|
chromosome 1 open reading frame 21 |
chr14_+_73704201 | 16.60 |
ENST00000340738.5
ENST00000427855.1 ENST00000381166.3 |
PAPLN
|
papilin, proteoglycan-like sulfated glycoprotein |
chr9_+_124030338 | 16.53 |
ENST00000449773.1
ENST00000432226.1 ENST00000436847.1 ENST00000394353.2 ENST00000449733.1 ENST00000412819.1 ENST00000341272.2 ENST00000373808.2 |
GSN
|
gelsolin |
chr8_+_136469684 | 16.52 |
ENST00000355849.5
|
KHDRBS3
|
KH domain containing, RNA binding, signal transduction associated 3 |
chr16_+_3096638 | 16.44 |
ENST00000336577.4
|
MMP25
|
matrix metallopeptidase 25 |
chr1_+_24882560 | 16.31 |
ENST00000374392.2
|
NCMAP
|
noncompact myelin associated protein |
chr20_-_48532019 | 16.13 |
ENST00000289431.5
|
SPATA2
|
spermatogenesis associated 2 |
chr14_+_96505659 | 16.11 |
ENST00000555004.1
|
C14orf132
|
chromosome 14 open reading frame 132 |
chr3_-_149688655 | 16.08 |
ENST00000461930.1
ENST00000423691.2 ENST00000490975.1 ENST00000461868.1 ENST00000452853.2 |
PFN2
|
profilin 2 |
chr5_-_146889619 | 16.05 |
ENST00000343218.5
|
DPYSL3
|
dihydropyrimidinase-like 3 |
chr12_-_53574418 | 16.01 |
ENST00000379843.3
ENST00000453446.2 ENST00000437073.1 |
CSAD
|
cysteine sulfinic acid decarboxylase |
chr18_-_72265035 | 15.94 |
ENST00000585279.1
ENST00000580048.1 |
LINC00909
|
long intergenic non-protein coding RNA 909 |
chr8_-_110703819 | 15.93 |
ENST00000532779.1
ENST00000534578.1 |
SYBU
|
syntabulin (syntaxin-interacting) |
chr19_-_18717627 | 15.74 |
ENST00000392386.3
|
CRLF1
|
cytokine receptor-like factor 1 |
chr1_+_9599540 | 15.74 |
ENST00000302692.6
|
SLC25A33
|
solute carrier family 25 (pyrimidine nucleotide carrier), member 33 |
chr4_-_5890145 | 15.48 |
ENST00000397890.2
|
CRMP1
|
collapsin response mediator protein 1 |
chr11_-_62389449 | 15.47 |
ENST00000534026.1
|
B3GAT3
|
beta-1,3-glucuronyltransferase 3 (glucuronosyltransferase I) |
chr9_-_91793675 | 15.41 |
ENST00000375835.4
ENST00000375830.1 |
SHC3
|
SHC (Src homology 2 domain containing) transforming protein 3 |
chr21_-_38338773 | 15.40 |
ENST00000399120.1
ENST00000419461.1 |
HLCS
|
holocarboxylase synthetase (biotin-(proprionyl-CoA-carboxylase (ATP-hydrolysing)) ligase) |
chr9_-_139922726 | 15.31 |
ENST00000265662.5
ENST00000371605.3 |
ABCA2
|
ATP-binding cassette, sub-family A (ABC1), member 2 |
chr20_+_23016057 | 15.20 |
ENST00000255008.3
|
SSTR4
|
somatostatin receptor 4 |
chr4_+_4388805 | 15.16 |
ENST00000504171.1
|
NSG1
|
Homo sapiens neuron specific gene family member 1 (NSG1), transcript variant 3, mRNA. |
chr4_-_5894777 | 15.07 |
ENST00000324989.7
|
CRMP1
|
collapsin response mediator protein 1 |
chr19_+_33685490 | 15.07 |
ENST00000253193.7
|
LRP3
|
low density lipoprotein receptor-related protein 3 |
chr13_+_27131887 | 14.92 |
ENST00000335327.5
|
WASF3
|
WAS protein family, member 3 |
chr1_+_3569072 | 14.87 |
ENST00000378295.4
ENST00000604074.1 |
TP73
|
tumor protein p73 |
chr1_-_11865982 | 14.86 |
ENST00000418034.1
|
MTHFR
|
methylenetetrahydrofolate reductase (NAD(P)H) |
chr21_-_34100341 | 14.78 |
ENST00000382499.2
ENST00000433931.2 |
SYNJ1
|
synaptojanin 1 |
chr15_-_72410350 | 14.71 |
ENST00000356056.5
ENST00000424560.1 ENST00000444904.1 |
MYO9A
|
myosin IXA |
chr9_-_140353748 | 14.57 |
ENST00000371472.2
ENST00000371475.3 ENST00000265663.7 ENST00000437259.1 ENST00000392812.4 ENST00000371474.3 ENST00000371473.3 |
NSMF
|
NMDA receptor synaptonuclear signaling and neuronal migration factor |
chr15_+_29131103 | 14.49 |
ENST00000558402.1
ENST00000558330.1 |
APBA2
|
amyloid beta (A4) precursor protein-binding, family A, member 2 |
chr19_+_16999654 | 14.49 |
ENST00000248076.3
|
F2RL3
|
coagulation factor II (thrombin) receptor-like 3 |
chr19_-_19006920 | 14.44 |
ENST00000429504.2
ENST00000427170.2 |
CERS1
|
ceramide synthase 1 |
chr16_+_85061367 | 14.41 |
ENST00000538274.1
ENST00000258180.3 |
KIAA0513
|
KIAA0513 |
chr6_+_19837592 | 14.28 |
ENST00000378700.3
|
ID4
|
inhibitor of DNA binding 4, dominant negative helix-loop-helix protein |
chr12_+_12878829 | 14.24 |
ENST00000326765.6
|
APOLD1
|
apolipoprotein L domain containing 1 |
chr19_-_2236290 | 14.21 |
ENST00000591099.2
ENST00000586608.2 ENST00000326631.2 ENST00000587962.2 |
PLEKHJ1
|
pleckstrin homology domain containing, family J member 1 |
chr1_+_3569129 | 14.14 |
ENST00000354437.4
ENST00000357733.3 ENST00000346387.4 |
TP73
|
tumor protein p73 |
chr19_+_10541462 | 14.13 |
ENST00000293683.5
|
PDE4A
|
phosphodiesterase 4A, cAMP-specific |
chr8_+_124194752 | 14.06 |
ENST00000318462.6
|
FAM83A
|
family with sequence similarity 83, member A |
chr3_-_52001448 | 14.05 |
ENST00000461554.1
ENST00000395013.3 ENST00000428823.2 ENST00000483411.1 ENST00000461544.1 ENST00000355852.2 |
PCBP4
|
poly(rC) binding protein 4 |
chrX_-_153363188 | 14.05 |
ENST00000303391.6
|
MECP2
|
methyl CpG binding protein 2 (Rett syndrome) |
chr9_-_136857403 | 14.03 |
ENST00000406606.3
ENST00000371850.3 |
VAV2
|
vav 2 guanine nucleotide exchange factor |
chr8_+_26435359 | 14.02 |
ENST00000311151.5
|
DPYSL2
|
dihydropyrimidinase-like 2 |
chr1_-_21948906 | 13.94 |
ENST00000374761.2
ENST00000599760.1 |
RAP1GAP
|
RAP1 GTPase activating protein |
chr16_+_1756162 | 13.90 |
ENST00000250894.4
ENST00000356010.5 |
MAPK8IP3
|
mitogen-activated protein kinase 8 interacting protein 3 |
chr1_-_54872059 | 13.85 |
ENST00000371320.3
|
SSBP3
|
single stranded DNA binding protein 3 |
chr17_-_10101868 | 13.74 |
ENST00000432992.2
ENST00000540214.1 |
GAS7
|
growth arrest-specific 7 |
chrX_-_8700171 | 13.72 |
ENST00000262648.3
|
KAL1
|
Kallmann syndrome 1 sequence |
chr5_+_149109825 | 13.71 |
ENST00000360453.4
ENST00000394320.3 ENST00000309241.5 |
PPARGC1B
|
peroxisome proliferator-activated receptor gamma, coactivator 1 beta |
chr7_+_98246588 | 13.71 |
ENST00000265634.3
|
NPTX2
|
neuronal pentraxin II |
chr1_-_21995794 | 13.70 |
ENST00000542643.2
ENST00000374765.4 ENST00000317967.7 |
RAP1GAP
|
RAP1 GTPase activating protein |
chr17_+_18163848 | 13.68 |
ENST00000323019.4
ENST00000578174.1 ENST00000395704.4 ENST00000395703.4 ENST00000578621.1 ENST00000579341.1 |
MIEF2
|
mitochondrial elongation factor 2 |
chr12_+_113376249 | 13.62 |
ENST00000551007.1
ENST00000548514.1 |
OAS3
|
2'-5'-oligoadenylate synthetase 3, 100kDa |
chr9_-_13279563 | 13.58 |
ENST00000541718.1
|
MPDZ
|
multiple PDZ domain protein |
chr1_+_156611704 | 13.56 |
ENST00000329117.5
|
BCAN
|
brevican |
chr12_+_119616447 | 13.54 |
ENST00000281938.2
|
HSPB8
|
heat shock 22kDa protein 8 |
chr16_-_75498308 | 13.52 |
ENST00000569540.1
|
TMEM170A
|
transmembrane protein 170A |
chr2_-_183903133 | 13.49 |
ENST00000361354.4
|
NCKAP1
|
NCK-associated protein 1 |
chr7_-_122526799 | 13.33 |
ENST00000334010.7
ENST00000313070.7 |
CADPS2
|
Ca++-dependent secretion activator 2 |
chr14_+_33408449 | 13.30 |
ENST00000346562.2
ENST00000341321.4 ENST00000548645.1 ENST00000356141.4 ENST00000357798.5 |
NPAS3
|
neuronal PAS domain protein 3 |
chr11_+_121322832 | 13.29 |
ENST00000260197.7
|
SORL1
|
sortilin-related receptor, L(DLR class) A repeats containing |
chr20_-_35492048 | 13.27 |
ENST00000237536.4
|
SOGA1
|
suppressor of glucose, autophagy associated 1 |
chr3_-_127541679 | 13.25 |
ENST00000265052.5
|
MGLL
|
monoglyceride lipase |
chr3_+_14989186 | 13.19 |
ENST00000435454.1
ENST00000323373.6 |
NR2C2
|
nuclear receptor subfamily 2, group C, member 2 |
chr7_+_2559399 | 13.17 |
ENST00000222725.5
ENST00000359574.3 |
LFNG
|
LFNG O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase |
chr1_-_85930823 | 13.16 |
ENST00000284031.8
ENST00000539042.1 |
DDAH1
|
dimethylarginine dimethylaminohydrolase 1 |
chr20_+_4667094 | 13.16 |
ENST00000424424.1
ENST00000457586.1 |
PRNP
|
prion protein |
chr9_+_129089088 | 13.15 |
ENST00000361171.3
ENST00000545391.1 |
MVB12B
|
multivesicular body subunit 12B |
chr7_-_73133959 | 13.07 |
ENST00000395155.3
ENST00000395154.3 ENST00000222812.3 ENST00000395156.3 |
STX1A
|
syntaxin 1A (brain) |
chr8_+_104513086 | 13.06 |
ENST00000406091.3
|
RIMS2
|
regulating synaptic membrane exocytosis 2 |
chr3_-_149688896 | 13.04 |
ENST00000239940.7
|
PFN2
|
profilin 2 |
chr8_-_33424636 | 13.03 |
ENST00000256257.1
|
RNF122
|
ring finger protein 122 |
chr12_-_53574671 | 13.01 |
ENST00000444623.1
|
CSAD
|
cysteine sulfinic acid decarboxylase |
chr14_-_101034407 | 12.92 |
ENST00000443071.2
ENST00000557378.1 |
BEGAIN
|
brain-enriched guanylate kinase-associated |
chr17_-_4167142 | 12.88 |
ENST00000570535.1
ENST00000574367.1 ENST00000341657.4 ENST00000433651.1 |
ANKFY1
|
ankyrin repeat and FYVE domain containing 1 |
chr19_-_49140609 | 12.87 |
ENST00000601104.1
|
DBP
|
D site of albumin promoter (albumin D-box) binding protein |
chr10_-_120514720 | 12.87 |
ENST00000369151.3
ENST00000340214.4 |
CACUL1
|
CDK2-associated, cullin domain 1 |
chr21_+_47878757 | 12.78 |
ENST00000400274.1
ENST00000427143.2 ENST00000318711.7 ENST00000457905.3 ENST00000466639.1 ENST00000435722.3 ENST00000417564.2 |
DIP2A
|
DIP2 disco-interacting protein 2 homolog A (Drosophila) |
chr9_-_130742792 | 12.77 |
ENST00000373095.1
|
FAM102A
|
family with sequence similarity 102, member A |
chr1_-_241520385 | 12.76 |
ENST00000366564.1
|
RGS7
|
regulator of G-protein signaling 7 |
chr12_-_112819896 | 12.73 |
ENST00000377560.5
ENST00000430131.2 ENST00000550722.1 ENST00000550724.1 |
HECTD4
|
HECT domain containing E3 ubiquitin protein ligase 4 |
chr12_+_125478241 | 12.67 |
ENST00000341446.8
|
BRI3BP
|
BRI3 binding protein |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
24.0 | 71.9 | GO:0021966 | corticospinal neuron axon guidance(GO:0021966) |
11.5 | 45.9 | GO:0042412 | taurine biosynthetic process(GO:0042412) |
11.0 | 88.3 | GO:0060160 | negative regulation of dopamine receptor signaling pathway(GO:0060160) |
10.4 | 31.3 | GO:0070940 | dephosphorylation of RNA polymerase II C-terminal domain(GO:0070940) |
10.2 | 30.5 | GO:1904617 | negative regulation of actin filament binding(GO:1904530) negative regulation of actin binding(GO:1904617) |
10.1 | 50.4 | GO:0061107 | seminal vesicle development(GO:0061107) |
9.4 | 18.7 | GO:2000820 | negative regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation(GO:2000820) |
9.3 | 27.8 | GO:2000048 | negative regulation of cell-cell adhesion mediated by cadherin(GO:2000048) |
9.2 | 27.7 | GO:0021718 | superior olivary nucleus development(GO:0021718) superior olivary nucleus maturation(GO:0021722) |
9.2 | 27.6 | GO:1903697 | negative regulation of microvillus assembly(GO:1903697) |
9.2 | 27.6 | GO:0007412 | axon target recognition(GO:0007412) regulation of synaptic vesicle fusion to presynaptic membrane(GO:0031630) |
9.0 | 36.0 | GO:1904978 | regulation of endosome organization(GO:1904978) |
8.7 | 78.7 | GO:0003190 | atrioventricular valve formation(GO:0003190) |
7.4 | 22.2 | GO:0014807 | regulation of somitogenesis(GO:0014807) |
7.3 | 22.0 | GO:1904647 | response to rotenone(GO:1904647) |
7.2 | 28.8 | GO:1990262 | regulation of anti-Mullerian hormone signaling pathway(GO:1902612) negative regulation of anti-Mullerian hormone signaling pathway(GO:1902613) anti-Mullerian hormone signaling pathway(GO:1990262) |
7.2 | 21.5 | GO:1902938 | regulation of intracellular calcium activated chloride channel activity(GO:1902938) |
7.2 | 14.4 | GO:0072134 | nephrogenic mesenchyme morphogenesis(GO:0072134) |
7.0 | 34.9 | GO:1904209 | regulation of chemokine (C-C motif) ligand 2 secretion(GO:1904207) positive regulation of chemokine (C-C motif) ligand 2 secretion(GO:1904209) |
6.8 | 87.8 | GO:2001135 | regulation of endocytic recycling(GO:2001135) |
6.6 | 19.8 | GO:0060168 | positive regulation of adenosine receptor signaling pathway(GO:0060168) |
6.6 | 32.8 | GO:0032377 | regulation of intracellular lipid transport(GO:0032377) regulation of intracellular sterol transport(GO:0032380) regulation of intracellular cholesterol transport(GO:0032383) |
6.5 | 91.3 | GO:0070050 | neuron cellular homeostasis(GO:0070050) |
6.4 | 19.2 | GO:0006258 | UDP-glucose catabolic process(GO:0006258) |
6.1 | 12.2 | GO:1990523 | bone regeneration(GO:1990523) |
6.0 | 18.1 | GO:0035408 | histone H3-T6 phosphorylation(GO:0035408) |
5.9 | 29.6 | GO:0060718 | chorionic trophoblast cell differentiation(GO:0060718) |
5.6 | 22.2 | GO:0044861 | protein transport into plasma membrane raft(GO:0044861) |
5.5 | 22.2 | GO:2000672 | negative regulation of motor neuron apoptotic process(GO:2000672) |
5.4 | 38.1 | GO:0071494 | cellular response to UV-C(GO:0071494) |
5.4 | 16.3 | GO:0032290 | peripheral nervous system myelin formation(GO:0032290) |
5.4 | 16.3 | GO:0030046 | parallel actin filament bundle assembly(GO:0030046) |
5.3 | 21.0 | GO:1903984 | positive regulation of TRAIL-activated apoptotic signaling pathway(GO:1903984) |
5.2 | 15.7 | GO:1990519 | pyrimidine nucleotide transport(GO:0006864) mitochondrial pyrimidine nucleotide import(GO:1990519) |
5.1 | 15.4 | GO:0070781 | response to biotin(GO:0070781) |
4.9 | 19.6 | GO:0060594 | mammary gland specification(GO:0060594) |
4.7 | 56.1 | GO:1900028 | negative regulation of ruffle assembly(GO:1900028) |
4.6 | 60.4 | GO:0051823 | regulation of synapse structural plasticity(GO:0051823) |
4.6 | 18.5 | GO:0006072 | glycerol-3-phosphate metabolic process(GO:0006072) negative regulation of protein kinase C signaling(GO:0090038) |
4.6 | 18.4 | GO:0032811 | negative regulation of epinephrine secretion(GO:0032811) epidermal growth factor-activated receptor transactivation by G-protein coupled receptor signaling pathway(GO:0035625) |
4.5 | 4.5 | GO:2000583 | regulation of platelet-derived growth factor receptor-alpha signaling pathway(GO:2000583) negative regulation of platelet-derived growth factor receptor-alpha signaling pathway(GO:2000584) |
4.4 | 39.5 | GO:2000467 | positive regulation of glycogen (starch) synthase activity(GO:2000467) |
4.2 | 46.1 | GO:0098887 | neurotransmitter receptor transport, endosome to postsynaptic membrane(GO:0098887) |
4.2 | 12.5 | GO:0032687 | negative regulation of interferon-alpha production(GO:0032687) |
4.2 | 12.5 | GO:1903233 | regulation of calcium ion-dependent exocytosis of neurotransmitter(GO:1903233) |
4.1 | 20.6 | GO:1990504 | dense core granule exocytosis(GO:1990504) |
4.1 | 8.1 | GO:0044333 | Wnt signaling pathway involved in digestive tract morphogenesis(GO:0044333) |
4.1 | 12.2 | GO:0003383 | apical constriction(GO:0003383) mesoderm migration involved in gastrulation(GO:0007509) |
4.1 | 20.3 | GO:0016191 | synaptic vesicle uncoating(GO:0016191) |
4.1 | 12.2 | GO:1990502 | dense core granule maturation(GO:1990502) |
3.9 | 7.7 | GO:1904204 | regulation of skeletal muscle hypertrophy(GO:1904204) |
3.8 | 11.5 | GO:0038098 | sequestering of BMP from receptor via BMP binding(GO:0038098) |
3.7 | 22.4 | GO:0021853 | cerebral cortex GABAergic interneuron migration(GO:0021853) interneuron migration(GO:1904936) |
3.7 | 29.5 | GO:1904262 | negative regulation of TORC1 signaling(GO:1904262) |
3.7 | 106.4 | GO:2000369 | regulation of clathrin-mediated endocytosis(GO:2000369) |
3.7 | 25.6 | GO:0021999 | neural plate anterior/posterior regionalization(GO:0021999) |
3.6 | 14.4 | GO:0071492 | cellular response to UV-A(GO:0071492) |
3.5 | 17.5 | GO:0097338 | response to clozapine(GO:0097338) |
3.5 | 27.6 | GO:0098532 | histone H3-K27 trimethylation(GO:0098532) |
3.3 | 23.4 | GO:0042670 | retinal cone cell differentiation(GO:0042670) retinal cone cell development(GO:0046549) |
3.3 | 10.0 | GO:0048511 | rhythmic process(GO:0048511) |
3.3 | 9.9 | GO:0071529 | cementum mineralization(GO:0071529) |
3.3 | 16.5 | GO:0044858 | plasma membrane raft distribution(GO:0044855) plasma membrane raft localization(GO:0044856) plasma membrane raft polarization(GO:0044858) regulation of plasma membrane raft polarization(GO:1903906) |
3.3 | 13.1 | GO:0010701 | positive regulation of norepinephrine secretion(GO:0010701) |
3.2 | 9.7 | GO:0090244 | Wnt signaling pathway involved in somitogenesis(GO:0090244) |
3.2 | 28.8 | GO:0035845 | photoreceptor cell outer segment organization(GO:0035845) |
3.2 | 28.4 | GO:0008090 | retrograde axonal transport(GO:0008090) |
3.1 | 12.5 | GO:0003219 | cardiac right ventricle formation(GO:0003219) |
3.1 | 9.4 | GO:1904933 | regulation of cell proliferation in midbrain(GO:1904933) |
3.1 | 6.2 | GO:0070863 | positive regulation of protein exit from endoplasmic reticulum(GO:0070863) |
3.1 | 15.3 | GO:2000170 | positive regulation of peptidyl-cysteine S-nitrosylation(GO:2000170) |
3.1 | 12.2 | GO:0072675 | multinuclear osteoclast differentiation(GO:0072674) osteoclast fusion(GO:0072675) |
3.0 | 15.2 | GO:0038169 | somatostatin receptor signaling pathway(GO:0038169) somatostatin signaling pathway(GO:0038170) |
3.0 | 14.9 | GO:0033274 | response to vitamin B2(GO:0033274) heterochromatin maintenance(GO:0070829) |
2.9 | 11.7 | GO:0090403 | oxidative stress-induced premature senescence(GO:0090403) |
2.9 | 20.4 | GO:0086046 | membrane depolarization during SA node cell action potential(GO:0086046) |
2.9 | 5.8 | GO:0021586 | pons maturation(GO:0021586) |
2.9 | 11.4 | GO:2001151 | regulation of renal water transport(GO:2001151) positive regulation of renal water transport(GO:2001153) |
2.9 | 11.4 | GO:1901162 | primary amino compound biosynthetic process(GO:1901162) |
2.8 | 8.5 | GO:1900369 | transcription, RNA-templated(GO:0001172) regulation of RNA interference(GO:1900368) negative regulation of RNA interference(GO:1900369) positive regulation of protein localization to nucleolus(GO:1904751) |
2.8 | 11.3 | GO:0014054 | positive regulation of gamma-aminobutyric acid secretion(GO:0014054) |
2.8 | 11.2 | GO:0060024 | rhythmic synaptic transmission(GO:0060024) |
2.7 | 8.2 | GO:1900063 | regulation of peroxisome organization(GO:1900063) |
2.7 | 10.9 | GO:1903691 | positive regulation of wound healing, spreading of epidermal cells(GO:1903691) |
2.7 | 8.1 | GO:0060437 | lung growth(GO:0060437) |
2.7 | 8.0 | GO:0031052 | mesodermal-endodermal cell signaling(GO:0003131) programmed DNA elimination(GO:0031049) chromosome breakage(GO:0031052) histone H2A-S139 phosphorylation(GO:0035978) positive regulation of cellular response to X-ray(GO:2000685) |
2.7 | 5.3 | GO:1990164 | histone H2A phosphorylation(GO:1990164) |
2.7 | 13.3 | GO:2001106 | regulation of Rho guanyl-nucleotide exchange factor activity(GO:2001106) |
2.6 | 13.2 | GO:0051388 | positive regulation of neurotrophin TRK receptor signaling pathway(GO:0051388) |
2.6 | 18.2 | GO:0060992 | response to fungicide(GO:0060992) |
2.6 | 23.0 | GO:2000601 | positive regulation of Arp2/3 complex-mediated actin nucleation(GO:2000601) |
2.5 | 20.2 | GO:0043129 | surfactant homeostasis(GO:0043129) |
2.5 | 12.6 | GO:0043654 | recognition of apoptotic cell(GO:0043654) |
2.5 | 22.2 | GO:0038007 | netrin-activated signaling pathway(GO:0038007) |
2.5 | 12.3 | GO:1904139 | positive regulation of odontogenesis of dentin-containing tooth(GO:0042488) mammary gland fat development(GO:0060611) positive regulation of macrophage colony-stimulating factor signaling pathway(GO:1902228) positive regulation of response to macrophage colony-stimulating factor(GO:1903971) positive regulation of cellular response to macrophage colony-stimulating factor stimulus(GO:1903974) microglial cell migration(GO:1904124) regulation of microglial cell migration(GO:1904139) positive regulation of microglial cell migration(GO:1904141) |
2.5 | 7.4 | GO:0044771 | meiotic cell cycle phase transition(GO:0044771) regulation of meiotic cell cycle phase transition(GO:1901993) negative regulation of meiotic cell cycle phase transition(GO:1901994) |
2.4 | 4.9 | GO:0070256 | negative regulation of circadian sleep/wake cycle, sleep(GO:0042321) negative regulation of circadian sleep/wake cycle, non-REM sleep(GO:0042323) negative regulation of mucus secretion(GO:0070256) |
2.4 | 2.4 | GO:0007497 | posterior midgut development(GO:0007497) |
2.4 | 35.8 | GO:0015671 | oxygen transport(GO:0015671) |
2.4 | 7.1 | GO:0061364 | apoptotic process involved in luteolysis(GO:0061364) |
2.4 | 9.4 | GO:0006114 | glycerol biosynthetic process(GO:0006114) |
2.3 | 11.4 | GO:0071321 | cellular response to cGMP(GO:0071321) |
2.3 | 27.2 | GO:1904321 | response to forskolin(GO:1904321) cellular response to forskolin(GO:1904322) |
2.3 | 9.0 | GO:0022027 | interkinetic nuclear migration(GO:0022027) |
2.2 | 6.6 | GO:0071373 | luteinizing hormone signaling pathway(GO:0042700) cellular response to luteinizing hormone stimulus(GO:0071373) |
2.2 | 24.1 | GO:0006930 | substrate-dependent cell migration, cell extension(GO:0006930) |
2.2 | 13.2 | GO:1900038 | negative regulation of cellular response to hypoxia(GO:1900038) |
2.2 | 6.5 | GO:0046952 | ketone body catabolic process(GO:0046952) |
2.2 | 10.9 | GO:0042539 | hypotonic salinity response(GO:0042539) cellular hypotonic salinity response(GO:0071477) |
2.1 | 12.9 | GO:0048549 | positive regulation of pinocytosis(GO:0048549) |
2.1 | 8.5 | GO:0072180 | mesonephric duct morphogenesis(GO:0072180) |
2.1 | 6.3 | GO:0070213 | protein auto-ADP-ribosylation(GO:0070213) |
2.1 | 10.5 | GO:0006651 | diacylglycerol biosynthetic process(GO:0006651) |
2.0 | 10.1 | GO:0030035 | microspike assembly(GO:0030035) |
2.0 | 44.6 | GO:0006646 | phosphatidylethanolamine biosynthetic process(GO:0006646) |
2.0 | 30.2 | GO:0071786 | endoplasmic reticulum tubular network organization(GO:0071786) |
2.0 | 8.0 | GO:0097089 | methyl-branched fatty acid metabolic process(GO:0097089) |
2.0 | 5.9 | GO:1900073 | regulation of neuromuscular synaptic transmission(GO:1900073) positive regulation of neuromuscular synaptic transmission(GO:1900075) |
2.0 | 17.8 | GO:0045646 | regulation of erythrocyte differentiation(GO:0045646) |
2.0 | 41.4 | GO:0001829 | trophectodermal cell differentiation(GO:0001829) |
1.9 | 5.8 | GO:0006566 | threonine metabolic process(GO:0006566) |
1.9 | 11.7 | GO:0051005 | negative regulation of lipoprotein lipase activity(GO:0051005) |
1.9 | 5.8 | GO:0072177 | mesonephric duct development(GO:0072177) |
1.9 | 9.7 | GO:0036016 | response to interleukin-3(GO:0036015) cellular response to interleukin-3(GO:0036016) |
1.9 | 9.6 | GO:0048133 | germ-line stem cell division(GO:0042078) male germ-line stem cell asymmetric division(GO:0048133) germline stem cell asymmetric division(GO:0098728) |
1.9 | 9.5 | GO:0009256 | 10-formyltetrahydrofolate metabolic process(GO:0009256) |
1.9 | 5.7 | GO:0051771 | negative regulation of nitric-oxide synthase biosynthetic process(GO:0051771) |
1.9 | 13.2 | GO:2000124 | regulation of endocannabinoid signaling pathway(GO:2000124) |
1.9 | 35.8 | GO:1901897 | regulation of relaxation of cardiac muscle(GO:1901897) |
1.9 | 20.6 | GO:0060022 | hard palate development(GO:0060022) |
1.9 | 7.5 | GO:0001826 | inner cell mass cell differentiation(GO:0001826) |
1.9 | 13.1 | GO:0098814 | spontaneous neurotransmitter secretion(GO:0061669) spontaneous synaptic transmission(GO:0098814) |
1.9 | 5.6 | GO:0010265 | SCF complex assembly(GO:0010265) |
1.8 | 12.9 | GO:0007256 | activation of JNKK activity(GO:0007256) |
1.8 | 9.1 | GO:0010606 | positive regulation of cytoplasmic mRNA processing body assembly(GO:0010606) |
1.8 | 14.5 | GO:0060155 | platelet dense granule organization(GO:0060155) |
1.8 | 5.4 | GO:0021538 | epithalamus development(GO:0021538) habenula development(GO:0021986) |
1.8 | 19.9 | GO:0048711 | positive regulation of astrocyte differentiation(GO:0048711) |
1.8 | 10.7 | GO:0034441 | plasma lipoprotein particle oxidation(GO:0034441) |
1.8 | 5.3 | GO:1905167 | positive regulation of lysosomal protein catabolic process(GO:1905167) |
1.8 | 5.3 | GO:0100009 | circadian temperature homeostasis(GO:0060086) regulation of fever generation by regulation of prostaglandin secretion(GO:0071810) positive regulation of fever generation by positive regulation of prostaglandin secretion(GO:0071812) positive regulation of ERK1 and ERK2 cascade via TNFSF11-mediated signaling(GO:0071848) regulation of fever generation by prostaglandin secretion(GO:0100009) |
1.8 | 22.9 | GO:0034638 | phosphatidylcholine catabolic process(GO:0034638) |
1.7 | 45.1 | GO:0045332 | lipid translocation(GO:0034204) phospholipid translocation(GO:0045332) |
1.7 | 5.2 | GO:2000173 | negative regulation of dendrite extension(GO:1903860) regulation of neuron remodeling(GO:1904799) negative regulation of neuron remodeling(GO:1904800) negative regulation of branching morphogenesis of a nerve(GO:2000173) |
1.7 | 6.9 | GO:0035616 | histone H2B conserved C-terminal lysine deubiquitination(GO:0035616) |
1.7 | 13.7 | GO:0006390 | transcription from mitochondrial promoter(GO:0006390) |
1.7 | 5.1 | GO:0038162 | erythropoietin-mediated signaling pathway(GO:0038162) |
1.7 | 17.1 | GO:0045964 | positive regulation of catecholamine metabolic process(GO:0045915) positive regulation of dopamine metabolic process(GO:0045964) |
1.7 | 29.0 | GO:0043508 | negative regulation of JUN kinase activity(GO:0043508) |
1.7 | 5.0 | GO:0010637 | negative regulation of mitochondrial fusion(GO:0010637) |
1.7 | 6.7 | GO:0002474 | antigen processing and presentation of peptide antigen via MHC class I(GO:0002474) |
1.7 | 16.6 | GO:0042118 | endothelial cell activation(GO:0042118) |
1.7 | 52.8 | GO:0008045 | motor neuron axon guidance(GO:0008045) |
1.6 | 9.9 | GO:0017196 | N-terminal peptidyl-methionine acetylation(GO:0017196) |
1.6 | 8.2 | GO:0090650 | rRNA transport(GO:0051029) response to oxygen-glucose deprivation(GO:0090649) cellular response to oxygen-glucose deprivation(GO:0090650) |
1.6 | 4.9 | GO:0043615 | astrocyte cell migration(GO:0043615) |
1.6 | 19.5 | GO:0099514 | anterograde synaptic vesicle transport(GO:0048490) synaptic vesicle cytoskeletal transport(GO:0099514) synaptic vesicle transport along microtubule(GO:0099517) |
1.6 | 8.0 | GO:1904100 | regulation of protein O-linked glycosylation(GO:1904098) positive regulation of protein O-linked glycosylation(GO:1904100) |
1.6 | 4.8 | GO:0019626 | short-chain fatty acid catabolic process(GO:0019626) |
1.6 | 9.5 | GO:0052422 | modulation by symbiont of host molecular function(GO:0052055) modulation of catalytic activity in other organism involved in symbiotic interaction(GO:0052203) modulation by host of symbiont catalytic activity(GO:0052422) |
1.5 | 6.2 | GO:0061762 | CAMKK-AMPK signaling cascade(GO:0061762) |
1.5 | 12.4 | GO:0021869 | forebrain ventricular zone progenitor cell division(GO:0021869) |
1.5 | 47.4 | GO:0050651 | dermatan sulfate proteoglycan biosynthetic process(GO:0050651) |
1.5 | 4.6 | GO:0097359 | UDP-glucosylation(GO:0097359) |
1.5 | 4.6 | GO:0051102 | DNA ligation involved in DNA recombination(GO:0051102) |
1.5 | 9.1 | GO:0052565 | response to defense-related nitric oxide production by other organism involved in symbiotic interaction(GO:0052551) response to defense-related host nitric oxide production(GO:0052565) |
1.5 | 16.7 | GO:2000427 | positive regulation of apoptotic cell clearance(GO:2000427) |
1.5 | 7.6 | GO:0061051 | positive regulation of cell growth involved in cardiac muscle cell development(GO:0061051) |
1.5 | 6.0 | GO:0032074 | negative regulation of nuclease activity(GO:0032074) |
1.5 | 14.9 | GO:0070830 | bicellular tight junction assembly(GO:0070830) |
1.5 | 11.9 | GO:1903142 | positive regulation of endothelial cell development(GO:1901552) positive regulation of establishment of endothelial barrier(GO:1903142) |
1.5 | 14.6 | GO:2001224 | positive regulation of neuron migration(GO:2001224) |
1.4 | 1.4 | GO:0003343 | proepicardium development(GO:0003342) septum transversum development(GO:0003343) |
1.4 | 8.6 | GO:0021819 | layer formation in cerebral cortex(GO:0021819) |
1.4 | 50.0 | GO:0009214 | cyclic nucleotide catabolic process(GO:0009214) |
1.4 | 2.9 | GO:0070307 | lens fiber cell development(GO:0070307) |
1.4 | 8.5 | GO:1904381 | Golgi apparatus mannose trimming(GO:1904381) |
1.4 | 8.5 | GO:0021957 | corticospinal tract morphogenesis(GO:0021957) |
1.4 | 6.9 | GO:0099538 | synaptic signaling via neuropeptide(GO:0099538) trans-synaptic signaling by neuropeptide(GO:0099540) trans-synaptic signaling by neuropeptide, modulating synaptic transmission(GO:0099551) |
1.4 | 9.7 | GO:0051639 | actin filament network formation(GO:0051639) |
1.4 | 13.7 | GO:0090141 | positive regulation of mitochondrial fission(GO:0090141) |
1.4 | 6.8 | GO:0032224 | positive regulation of synaptic transmission, cholinergic(GO:0032224) |
1.3 | 9.4 | GO:0043634 | polyadenylation-dependent RNA catabolic process(GO:0043633) polyadenylation-dependent ncRNA catabolic process(GO:0043634) |
1.3 | 9.4 | GO:0042126 | nitrate metabolic process(GO:0042126) |
1.3 | 10.7 | GO:0061314 | Notch signaling involved in heart development(GO:0061314) |
1.3 | 17.4 | GO:0002031 | G-protein coupled receptor internalization(GO:0002031) |
1.3 | 6.7 | GO:0034334 | adherens junction maintenance(GO:0034334) |
1.3 | 8.0 | GO:0051694 | pointed-end actin filament capping(GO:0051694) |
1.3 | 4.0 | GO:0090298 | negative regulation of mitochondrial DNA replication(GO:0090298) negative regulation of mitochondrial DNA metabolic process(GO:1901859) |
1.3 | 7.8 | GO:0034454 | microtubule anchoring at centrosome(GO:0034454) |
1.3 | 7.8 | GO:0098722 | asymmetric neuroblast division(GO:0055059) asymmetric stem cell division(GO:0098722) |
1.3 | 23.3 | GO:0032060 | bleb assembly(GO:0032060) |
1.3 | 6.4 | GO:1990034 | calcium ion export from cell(GO:1990034) |
1.3 | 6.4 | GO:0000189 | MAPK import into nucleus(GO:0000189) |
1.3 | 19.2 | GO:0033539 | fatty acid beta-oxidation using acyl-CoA dehydrogenase(GO:0033539) |
1.3 | 3.8 | GO:0017186 | peptidyl-pyroglutamic acid biosynthetic process, using glutaminyl-peptide cyclotransferase(GO:0017186) |
1.3 | 46.4 | GO:0007194 | negative regulation of adenylate cyclase activity(GO:0007194) |
1.3 | 12.5 | GO:0030322 | stabilization of membrane potential(GO:0030322) |
1.3 | 6.3 | GO:0018125 | peptidyl-cysteine methylation(GO:0018125) minus-end-directed organelle transport along microtubule(GO:0072385) |
1.2 | 7.4 | GO:1903244 | positive regulation of cardiac muscle adaptation(GO:0010615) positive regulation of cardiac muscle hypertrophy in response to stress(GO:1903244) |
1.2 | 3.7 | GO:0050882 | voluntary musculoskeletal movement(GO:0050882) |
1.2 | 7.1 | GO:0046929 | negative regulation of neurotransmitter secretion(GO:0046929) |
1.2 | 3.5 | GO:0036071 | N-glycan fucosylation(GO:0036071) |
1.2 | 3.5 | GO:1902951 | negative regulation of dendritic spine maintenance(GO:1902951) |
1.2 | 10.6 | GO:1903140 | regulation of endothelial cell development(GO:1901550) regulation of establishment of endothelial barrier(GO:1903140) |
1.2 | 8.2 | GO:0046855 | inositol phosphate dephosphorylation(GO:0046855) |
1.1 | 3.4 | GO:0043068 | positive regulation of apoptotic process(GO:0043065) positive regulation of programmed cell death(GO:0043068) |
1.1 | 17.0 | GO:0071318 | cellular response to ATP(GO:0071318) |
1.1 | 6.5 | GO:0048619 | embryonic hindgut morphogenesis(GO:0048619) |
1.1 | 8.7 | GO:0060355 | positive regulation of cell adhesion molecule production(GO:0060355) |
1.1 | 11.9 | GO:2000576 | positive regulation of microtubule motor activity(GO:2000576) regulation of ATP-dependent microtubule motor activity, plus-end-directed(GO:2000580) positive regulation of ATP-dependent microtubule motor activity, plus-end-directed(GO:2000582) |
1.1 | 3.2 | GO:1902490 | regulation of sperm capacitation(GO:1902490) |
1.1 | 2.1 | GO:0003348 | cardiac endothelial cell differentiation(GO:0003348) endocardial cell differentiation(GO:0060956) |
1.1 | 2.1 | GO:0031133 | regulation of axon diameter(GO:0031133) |
1.1 | 6.4 | GO:0060013 | righting reflex(GO:0060013) |
1.1 | 10.6 | GO:0060700 | regulation of ribonuclease activity(GO:0060700) |
1.1 | 2.1 | GO:0031860 | telomeric 3' overhang formation(GO:0031860) |
1.1 | 10.6 | GO:0010457 | centriole-centriole cohesion(GO:0010457) |
1.0 | 19.8 | GO:0035988 | chondrocyte proliferation(GO:0035988) |
1.0 | 5.2 | GO:0009636 | response to toxic substance(GO:0009636) |
1.0 | 7.2 | GO:0016322 | neuron remodeling(GO:0016322) |
1.0 | 59.3 | GO:0050885 | neuromuscular process controlling balance(GO:0050885) |
1.0 | 6.1 | GO:0070164 | negative regulation of adiponectin secretion(GO:0070164) |
1.0 | 2.0 | GO:0098868 | endochondral bone growth(GO:0003416) bone growth(GO:0098868) |
1.0 | 9.0 | GO:0019509 | L-methionine biosynthetic process from methylthioadenosine(GO:0019509) |
1.0 | 5.0 | GO:0010571 | positive regulation of nuclear cell cycle DNA replication(GO:0010571) |
1.0 | 8.9 | GO:0006729 | tetrahydrobiopterin biosynthetic process(GO:0006729) tetrahydrobiopterin metabolic process(GO:0046146) |
1.0 | 3.9 | GO:0016198 | axon choice point recognition(GO:0016198) |
1.0 | 4.9 | GO:0061511 | centriole elongation(GO:0061511) |
1.0 | 13.7 | GO:0000725 | double-strand break repair via homologous recombination(GO:0000724) recombinational repair(GO:0000725) |
1.0 | 24.4 | GO:0039703 | viral RNA genome replication(GO:0039694) RNA replication(GO:0039703) |
1.0 | 6.8 | GO:0035897 | proteolysis in other organism(GO:0035897) |
1.0 | 23.2 | GO:0061003 | positive regulation of dendritic spine morphogenesis(GO:0061003) |
1.0 | 1.0 | GO:0003241 | growth involved in heart morphogenesis(GO:0003241) |
1.0 | 11.6 | GO:0060670 | branching involved in labyrinthine layer morphogenesis(GO:0060670) |
1.0 | 6.7 | GO:0046618 | drug export(GO:0046618) |
1.0 | 5.7 | GO:0072364 | regulation of cellular ketone metabolic process by regulation of transcription from RNA polymerase II promoter(GO:0072364) |
1.0 | 11.5 | GO:0045721 | negative regulation of gluconeogenesis(GO:0045721) |
1.0 | 3.8 | GO:0030705 | cytoskeleton-dependent intracellular transport(GO:0030705) |
1.0 | 10.5 | GO:0042711 | maternal behavior(GO:0042711) parental behavior(GO:0060746) |
0.9 | 32.4 | GO:0070884 | regulation of calcineurin-NFAT signaling cascade(GO:0070884) |
0.9 | 7.4 | GO:0046325 | negative regulation of glucose import(GO:0046325) |
0.9 | 21.2 | GO:0031643 | positive regulation of myelination(GO:0031643) |
0.9 | 3.7 | GO:0019086 | regulation of transcription from RNA polymerase II promoter by glucose(GO:0000430) positive regulation of transcription from RNA polymerase II promoter by glucose(GO:0000432) late viral transcription(GO:0019086) positive regulation of transcription by glucose(GO:0046016) |
0.9 | 9.1 | GO:0043249 | erythrocyte maturation(GO:0043249) |
0.9 | 0.9 | GO:1901341 | activation of store-operated calcium channel activity(GO:0032237) regulation of store-operated calcium channel activity(GO:1901339) positive regulation of store-operated calcium channel activity(GO:1901341) |
0.9 | 16.3 | GO:0010510 | regulation of acetyl-CoA biosynthetic process from pyruvate(GO:0010510) |
0.9 | 11.7 | GO:0008089 | anterograde axonal transport(GO:0008089) |
0.9 | 7.2 | GO:0046007 | negative regulation of activated T cell proliferation(GO:0046007) |
0.9 | 7.2 | GO:0034086 | maintenance of sister chromatid cohesion(GO:0034086) maintenance of mitotic sister chromatid cohesion(GO:0034088) |
0.9 | 5.3 | GO:0070172 | positive regulation of tooth mineralization(GO:0070172) |
0.9 | 16.0 | GO:0051764 | actin crosslink formation(GO:0051764) |
0.9 | 8.9 | GO:0034983 | peptidyl-lysine deacetylation(GO:0034983) |
0.9 | 9.7 | GO:2000288 | positive regulation of myoblast proliferation(GO:2000288) |
0.9 | 2.6 | GO:0046010 | positive regulation of circadian sleep/wake cycle, non-REM sleep(GO:0046010) |
0.8 | 6.8 | GO:0045905 | translational frameshifting(GO:0006452) positive regulation of translational termination(GO:0045905) |
0.8 | 8.5 | GO:0001867 | complement activation, lectin pathway(GO:0001867) |
0.8 | 8.5 | GO:0031274 | positive regulation of pseudopodium assembly(GO:0031274) |
0.8 | 1.7 | GO:2000304 | positive regulation of sphingolipid biosynthetic process(GO:0090154) positive regulation of ceramide biosynthetic process(GO:2000304) |
0.8 | 7.5 | GO:0006338 | chromatin remodeling(GO:0006338) |
0.8 | 5.0 | GO:0035021 | negative regulation of Rac protein signal transduction(GO:0035021) |
0.8 | 2.5 | GO:0033184 | positive regulation of histone ubiquitination(GO:0033184) regulation of histone H2B ubiquitination(GO:2001166) positive regulation of histone H2B ubiquitination(GO:2001168) |
0.8 | 7.4 | GO:0090037 | positive regulation of protein kinase C signaling(GO:0090037) |
0.8 | 5.7 | GO:0071670 | smooth muscle cell chemotaxis(GO:0071670) |
0.8 | 9.7 | GO:0014848 | urinary bladder smooth muscle contraction(GO:0014832) urinary tract smooth muscle contraction(GO:0014848) |
0.8 | 3.9 | GO:0033173 | calcineurin-NFAT signaling cascade(GO:0033173) |
0.8 | 6.2 | GO:0045657 | positive regulation of monocyte differentiation(GO:0045657) |
0.8 | 14.7 | GO:0061154 | endothelial tube morphogenesis(GO:0061154) |
0.8 | 4.6 | GO:1900748 | positive regulation of vascular endothelial growth factor signaling pathway(GO:1900748) |
0.7 | 19.4 | GO:0097503 | sialylation(GO:0097503) |
0.7 | 3.7 | GO:0060294 | cilium movement involved in cell motility(GO:0060294) |
0.7 | 14.7 | GO:0005513 | detection of calcium ion(GO:0005513) |
0.7 | 7.3 | GO:0030913 | paranodal junction assembly(GO:0030913) |
0.7 | 5.1 | GO:0040032 | post-embryonic body morphogenesis(GO:0040032) regulation of parathyroid hormone secretion(GO:2000828) |
0.7 | 2.2 | GO:1903401 | lysine import(GO:0034226) L-lysine import(GO:0061461) L-lysine transmembrane transport(GO:1903401) L-lysine import into cell(GO:1903410) |
0.7 | 11.5 | GO:0034643 | establishment of mitochondrion localization, microtubule-mediated(GO:0034643) mitochondrion transport along microtubule(GO:0047497) |
0.7 | 11.4 | GO:0032836 | glomerular basement membrane development(GO:0032836) |
0.7 | 2.1 | GO:0050720 | regulation of interleukin-1 biosynthetic process(GO:0045360) positive regulation of interleukin-1 biosynthetic process(GO:0045362) interleukin-1 beta biosynthetic process(GO:0050720) |
0.7 | 3.6 | GO:0070166 | enamel mineralization(GO:0070166) |
0.7 | 3.5 | GO:0021527 | spinal cord association neuron differentiation(GO:0021527) |
0.7 | 5.6 | GO:0003338 | metanephros morphogenesis(GO:0003338) |
0.7 | 2.1 | GO:0048294 | negative regulation of isotype switching to IgE isotypes(GO:0048294) |
0.7 | 4.8 | GO:0097151 | positive regulation of inhibitory postsynaptic potential(GO:0097151) modulation of inhibitory postsynaptic potential(GO:0098828) |
0.7 | 22.0 | GO:0006783 | heme biosynthetic process(GO:0006783) |
0.7 | 10.9 | GO:2001241 | positive regulation of extrinsic apoptotic signaling pathway in absence of ligand(GO:2001241) |
0.7 | 11.5 | GO:0090090 | negative regulation of canonical Wnt signaling pathway(GO:0090090) |
0.7 | 3.3 | GO:0060004 | reflex(GO:0060004) |
0.7 | 15.2 | GO:0060997 | dendritic spine morphogenesis(GO:0060997) |
0.7 | 2.0 | GO:0075071 | autophagy of host cells involved in interaction with symbiont(GO:0075044) autophagy involved in symbiotic interaction(GO:0075071) |
0.7 | 9.3 | GO:0097264 | self proteolysis(GO:0097264) |
0.7 | 5.3 | GO:0016926 | protein desumoylation(GO:0016926) |
0.7 | 2.6 | GO:0048631 | regulation of skeletal muscle tissue growth(GO:0048631) |
0.7 | 9.2 | GO:2000480 | negative regulation of cAMP-dependent protein kinase activity(GO:2000480) |
0.7 | 3.9 | GO:0072661 | protein targeting to plasma membrane(GO:0072661) |
0.6 | 1.9 | GO:0034427 | nuclear-transcribed mRNA catabolic process, exonucleolytic, 3'-5'(GO:0034427) |
0.6 | 1.9 | GO:0006535 | cysteine biosynthetic process from serine(GO:0006535) |
0.6 | 1.9 | GO:0070105 | positive regulation of interleukin-6-mediated signaling pathway(GO:0070105) |
0.6 | 1.2 | GO:0003199 | endocardial cushion to mesenchymal transition involved in heart valve formation(GO:0003199) |
0.6 | 7.7 | GO:0048820 | hair follicle maturation(GO:0048820) |
0.6 | 5.9 | GO:0048102 | autophagic cell death(GO:0048102) |
0.6 | 11.9 | GO:0032012 | regulation of ARF protein signal transduction(GO:0032012) |
0.6 | 5.9 | GO:0002244 | hematopoietic progenitor cell differentiation(GO:0002244) |
0.6 | 5.3 | GO:0046578 | regulation of Ras protein signal transduction(GO:0046578) |
0.6 | 1.7 | GO:0021997 | neural plate axis specification(GO:0021997) |
0.6 | 5.7 | GO:0045161 | neuronal ion channel clustering(GO:0045161) |
0.6 | 2.3 | GO:0015808 | L-alanine transport(GO:0015808) |
0.6 | 5.7 | GO:0060841 | venous blood vessel development(GO:0060841) |
0.6 | 1.7 | GO:0009447 | putrescine catabolic process(GO:0009447) |
0.6 | 3.4 | GO:0098535 | de novo centriole assembly(GO:0098535) |
0.6 | 2.2 | GO:0007018 | microtubule-based movement(GO:0007018) |
0.6 | 6.2 | GO:0030050 | vesicle transport along actin filament(GO:0030050) |
0.5 | 1.6 | GO:0038165 | oncostatin-M-mediated signaling pathway(GO:0038165) |
0.5 | 3.8 | GO:0045198 | establishment of epithelial cell apical/basal polarity(GO:0045198) |
0.5 | 7.6 | GO:0021854 | hypothalamus development(GO:0021854) |
0.5 | 5.4 | GO:0006975 | DNA damage induced protein phosphorylation(GO:0006975) |
0.5 | 4.3 | GO:0021904 | dorsal/ventral neural tube patterning(GO:0021904) |
0.5 | 3.7 | GO:0006572 | tyrosine catabolic process(GO:0006572) |
0.5 | 1.6 | GO:0021919 | BMP signaling pathway involved in spinal cord dorsal/ventral patterning(GO:0021919) |
0.5 | 9.9 | GO:0034375 | high-density lipoprotein particle remodeling(GO:0034375) |
0.5 | 3.6 | GO:0048104 | establishment of body hair or bristle planar orientation(GO:0048104) establishment of body hair planar orientation(GO:0048105) |
0.5 | 2.6 | GO:0036414 | protein citrullination(GO:0018101) histone citrullination(GO:0036414) |
0.5 | 4.1 | GO:2000042 | negative regulation of double-strand break repair via homologous recombination(GO:2000042) |
0.5 | 31.9 | GO:0061178 | regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0061178) |
0.5 | 9.2 | GO:0009312 | oligosaccharide biosynthetic process(GO:0009312) |
0.5 | 9.2 | GO:0070262 | peptidyl-serine dephosphorylation(GO:0070262) |
0.5 | 4.5 | GO:0033127 | regulation of histone phosphorylation(GO:0033127) |
0.5 | 8.0 | GO:0030032 | lamellipodium assembly(GO:0030032) |
0.5 | 10.5 | GO:0048791 | calcium ion-regulated exocytosis of neurotransmitter(GO:0048791) |
0.5 | 4.0 | GO:0098719 | sodium ion import across plasma membrane(GO:0098719) sodium ion import into cell(GO:1990118) |
0.5 | 12.3 | GO:1900449 | regulation of glutamate receptor signaling pathway(GO:1900449) |
0.5 | 2.0 | GO:2000857 | positive regulation of mineralocorticoid secretion(GO:2000857) positive regulation of aldosterone secretion(GO:2000860) |
0.5 | 0.5 | GO:0036289 | peptidyl-serine autophosphorylation(GO:0036289) |
0.5 | 4.9 | GO:0008038 | neuron recognition(GO:0008038) |
0.5 | 12.0 | GO:0010738 | regulation of protein kinase A signaling(GO:0010738) |
0.5 | 3.3 | GO:0034453 | microtubule anchoring(GO:0034453) |
0.5 | 12.3 | GO:0010862 | positive regulation of pathway-restricted SMAD protein phosphorylation(GO:0010862) |
0.5 | 15.5 | GO:0019933 | cAMP-mediated signaling(GO:0019933) |
0.5 | 1.9 | GO:0075509 | receptor-mediated endocytosis of virus by host cell(GO:0019065) endocytosis involved in viral entry into host cell(GO:0075509) |
0.5 | 0.5 | GO:0072178 | nephric duct development(GO:0072176) nephric duct morphogenesis(GO:0072178) |
0.5 | 8.7 | GO:0032957 | inositol trisphosphate metabolic process(GO:0032957) |
0.5 | 1.4 | GO:0034146 | toll-like receptor 5 signaling pathway(GO:0034146) |
0.5 | 4.1 | GO:2001197 | regulation of basement membrane assembly involved in embryonic body morphogenesis(GO:1904259) positive regulation of basement membrane assembly involved in embryonic body morphogenesis(GO:1904261) basement membrane assembly involved in embryonic body morphogenesis(GO:2001197) |
0.4 | 13.9 | GO:0007257 | activation of JUN kinase activity(GO:0007257) |
0.4 | 1.8 | GO:0042986 | positive regulation of amyloid precursor protein biosynthetic process(GO:0042986) |
0.4 | 1.8 | GO:0060729 | intestinal epithelial structure maintenance(GO:0060729) |
0.4 | 4.4 | GO:0055123 | digestive system development(GO:0055123) |
0.4 | 3.0 | GO:0090344 | negative regulation of cell aging(GO:0090344) |
0.4 | 6.7 | GO:0030030 | cell projection organization(GO:0030030) |
0.4 | 1.3 | GO:0072284 | thyroid-stimulating hormone secretion(GO:0070460) comma-shaped body morphogenesis(GO:0072049) S-shaped body morphogenesis(GO:0072050) metanephric comma-shaped body morphogenesis(GO:0072278) metanephric S-shaped body morphogenesis(GO:0072284) regulation of thyroid-stimulating hormone secretion(GO:2000612) |
0.4 | 6.2 | GO:0016576 | histone dephosphorylation(GO:0016576) |
0.4 | 2.5 | GO:0032483 | regulation of Rab protein signal transduction(GO:0032483) |
0.4 | 1.2 | GO:0071267 | amino acid salvage(GO:0043102) L-methionine salvage(GO:0071267) |
0.4 | 5.7 | GO:0009650 | UV protection(GO:0009650) |
0.4 | 3.3 | GO:0070544 | histone H3-K36 demethylation(GO:0070544) |
0.4 | 3.2 | GO:0006659 | phosphatidylserine biosynthetic process(GO:0006659) |
0.4 | 2.8 | GO:0048710 | regulation of astrocyte differentiation(GO:0048710) |
0.4 | 2.4 | GO:0045945 | positive regulation of transcription from RNA polymerase III promoter(GO:0045945) |
0.4 | 9.0 | GO:0009435 | NAD biosynthetic process(GO:0009435) |
0.4 | 3.1 | GO:1900122 | positive regulation of receptor binding(GO:1900122) |
0.4 | 8.5 | GO:2001275 | positive regulation of glucose import in response to insulin stimulus(GO:2001275) |
0.4 | 2.3 | GO:0006196 | AMP catabolic process(GO:0006196) |
0.4 | 2.7 | GO:0071394 | cellular response to testosterone stimulus(GO:0071394) |
0.4 | 3.0 | GO:0042532 | negative regulation of tyrosine phosphorylation of STAT protein(GO:0042532) |
0.4 | 20.7 | GO:0030516 | regulation of axon extension(GO:0030516) |
0.4 | 12.5 | GO:0090102 | cochlea development(GO:0090102) |
0.4 | 5.1 | GO:1904380 | endoplasmic reticulum mannose trimming(GO:1904380) |
0.4 | 9.7 | GO:1900087 | positive regulation of G1/S transition of mitotic cell cycle(GO:1900087) |
0.4 | 9.3 | GO:0051058 | negative regulation of Ras protein signal transduction(GO:0046580) negative regulation of small GTPase mediated signal transduction(GO:0051058) |
0.4 | 1.4 | GO:0097084 | vascular smooth muscle cell development(GO:0097084) |
0.3 | 4.2 | GO:0045919 | positive regulation of cytolysis(GO:0045919) |
0.3 | 2.4 | GO:2000114 | regulation of establishment of cell polarity(GO:2000114) |
0.3 | 15.0 | GO:0042059 | negative regulation of epidermal growth factor receptor signaling pathway(GO:0042059) |
0.3 | 1.3 | GO:0048703 | embryonic viscerocranium morphogenesis(GO:0048703) |
0.3 | 2.3 | GO:0006779 | porphyrin-containing compound biosynthetic process(GO:0006779) |
0.3 | 1.6 | GO:0006546 | glycine catabolic process(GO:0006546) glycine decarboxylation via glycine cleavage system(GO:0019464) |
0.3 | 3.9 | GO:0010944 | negative regulation of transcription by competitive promoter binding(GO:0010944) |
0.3 | 2.2 | GO:0070459 | prolactin secretion(GO:0070459) |
0.3 | 19.6 | GO:0042147 | retrograde transport, endosome to Golgi(GO:0042147) |
0.3 | 4.3 | GO:0051256 | mitotic spindle midzone assembly(GO:0051256) |
0.3 | 0.9 | GO:0001955 | blood vessel maturation(GO:0001955) |
0.3 | 7.1 | GO:0019373 | epoxygenase P450 pathway(GO:0019373) |
0.3 | 2.2 | GO:0051418 | interphase microtubule nucleation by interphase microtubule organizing center(GO:0051415) microtubule nucleation by microtubule organizing center(GO:0051418) |
0.3 | 2.4 | GO:0006600 | creatine metabolic process(GO:0006600) |
0.3 | 2.4 | GO:0038063 | collagen-activated tyrosine kinase receptor signaling pathway(GO:0038063) |
0.3 | 6.3 | GO:0071108 | protein K48-linked deubiquitination(GO:0071108) |
0.3 | 2.4 | GO:1990403 | embryonic brain development(GO:1990403) |
0.3 | 3.0 | GO:0071539 | protein localization to centrosome(GO:0071539) |
0.3 | 20.1 | GO:0042308 | negative regulation of protein import into nucleus(GO:0042308) negative regulation of protein import(GO:1904590) |
0.3 | 2.6 | GO:0035269 | protein O-linked mannosylation(GO:0035269) |
0.3 | 2.9 | GO:0050965 | detection of temperature stimulus involved in sensory perception(GO:0050961) detection of temperature stimulus involved in sensory perception of pain(GO:0050965) |
0.3 | 1.4 | GO:0071447 | cellular response to hydroperoxide(GO:0071447) |
0.3 | 1.7 | GO:0006006 | glucose metabolic process(GO:0006006) |
0.3 | 1.9 | GO:1903025 | regulation of RNA polymerase II regulatory region sequence-specific DNA binding(GO:1903025) |
0.3 | 3.6 | GO:0043517 | positive regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043517) |
0.3 | 3.0 | GO:0050909 | sensory perception of taste(GO:0050909) |
0.3 | 2.9 | GO:0035116 | embryonic hindlimb morphogenesis(GO:0035116) |
0.3 | 5.6 | GO:0016577 | histone demethylation(GO:0016577) |
0.3 | 5.0 | GO:0003091 | renal water homeostasis(GO:0003091) |
0.3 | 2.1 | GO:0046827 | positive regulation of protein export from nucleus(GO:0046827) |
0.3 | 4.8 | GO:0006099 | tricarboxylic acid cycle(GO:0006099) |
0.3 | 5.3 | GO:0007597 | blood coagulation, intrinsic pathway(GO:0007597) |
0.3 | 1.8 | GO:2000189 | positive regulation of cholesterol homeostasis(GO:2000189) |
0.3 | 6.8 | GO:0036151 | phosphatidylcholine acyl-chain remodeling(GO:0036151) phosphatidylethanolamine acyl-chain remodeling(GO:0036152) |
0.3 | 12.7 | GO:0015701 | bicarbonate transport(GO:0015701) |
0.2 | 7.2 | GO:0035249 | synaptic transmission, glutamatergic(GO:0035249) |
0.2 | 1.5 | GO:0007296 | vitellogenesis(GO:0007296) |
0.2 | 4.7 | GO:0009395 | phospholipid catabolic process(GO:0009395) |
0.2 | 4.7 | GO:0015012 | heparan sulfate proteoglycan biosynthetic process(GO:0015012) |
0.2 | 6.1 | GO:1900026 | positive regulation of substrate adhesion-dependent cell spreading(GO:1900026) |
0.2 | 1.9 | GO:0007368 | determination of left/right symmetry(GO:0007368) |
0.2 | 4.3 | GO:0043507 | positive regulation of JUN kinase activity(GO:0043507) |
0.2 | 12.0 | GO:0008285 | negative regulation of cell proliferation(GO:0008285) |
0.2 | 3.6 | GO:0051898 | negative regulation of protein kinase B signaling(GO:0051898) |
0.2 | 17.4 | GO:0032273 | positive regulation of protein polymerization(GO:0032273) |
0.2 | 5.0 | GO:1901522 | positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus(GO:1901522) |
0.2 | 2.6 | GO:2000346 | negative regulation of hepatocyte proliferation(GO:2000346) |
0.2 | 1.9 | GO:0009798 | axis specification(GO:0009798) |
0.2 | 1.9 | GO:0050769 | positive regulation of neurogenesis(GO:0050769) |
0.2 | 2.8 | GO:0048147 | negative regulation of fibroblast proliferation(GO:0048147) |
0.2 | 29.3 | GO:0035023 | regulation of Rho protein signal transduction(GO:0035023) |
0.2 | 42.9 | GO:0050953 | visual perception(GO:0007601) sensory perception of light stimulus(GO:0050953) |
0.2 | 3.7 | GO:0021772 | olfactory bulb development(GO:0021772) olfactory lobe development(GO:0021988) |
0.2 | 2.3 | GO:0036066 | protein O-linked fucosylation(GO:0036066) |
0.2 | 0.7 | GO:0006537 | glutamate biosynthetic process(GO:0006537) |
0.2 | 6.7 | GO:0035115 | embryonic forelimb morphogenesis(GO:0035115) |
0.2 | 5.3 | GO:0035235 | ionotropic glutamate receptor signaling pathway(GO:0035235) |
0.2 | 7.0 | GO:0001942 | hair follicle development(GO:0001942) |
0.2 | 0.8 | GO:0010172 | embryonic body morphogenesis(GO:0010172) |
0.2 | 1.4 | GO:0010002 | cardioblast differentiation(GO:0010002) |
0.2 | 2.4 | GO:0072583 | clathrin-mediated endocytosis(GO:0072583) |
0.2 | 3.8 | GO:0032570 | response to progesterone(GO:0032570) |
0.2 | 3.0 | GO:0060113 | inner ear receptor cell differentiation(GO:0060113) |
0.2 | 2.3 | GO:0045475 | locomotor rhythm(GO:0045475) |
0.2 | 5.7 | GO:0009268 | response to pH(GO:0009268) |
0.2 | 1.7 | GO:0019885 | antigen processing and presentation of endogenous peptide antigen via MHC class I(GO:0019885) |
0.2 | 0.5 | GO:0030327 | prenylated protein catabolic process(GO:0030327) |
0.2 | 4.8 | GO:0007193 | adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway(GO:0007193) |
0.2 | 5.2 | GO:0008306 | associative learning(GO:0008306) |
0.2 | 7.5 | GO:0035914 | skeletal muscle cell differentiation(GO:0035914) |
0.2 | 2.2 | GO:0018345 | protein palmitoylation(GO:0018345) |
0.2 | 2.1 | GO:0001977 | renal system process involved in regulation of blood volume(GO:0001977) |
0.2 | 1.9 | GO:0070734 | histone H3-K27 methylation(GO:0070734) |
0.2 | 2.3 | GO:0032780 | negative regulation of ATPase activity(GO:0032780) |
0.2 | 6.7 | GO:0008156 | negative regulation of DNA replication(GO:0008156) |
0.2 | 0.2 | GO:0042137 | sequestering of neurotransmitter(GO:0042137) |
0.2 | 0.5 | GO:0034154 | toll-like receptor 7 signaling pathway(GO:0034154) |
0.1 | 1.9 | GO:0032988 | ribonucleoprotein complex disassembly(GO:0032988) |
0.1 | 3.7 | GO:0021954 | central nervous system neuron development(GO:0021954) |
0.1 | 1.0 | GO:0007020 | microtubule nucleation(GO:0007020) |
0.1 | 1.4 | GO:0010992 | ubiquitin homeostasis(GO:0010992) |
0.1 | 0.8 | GO:0015732 | prostaglandin transport(GO:0015732) |
0.1 | 2.5 | GO:0050982 | detection of mechanical stimulus(GO:0050982) |
0.1 | 1.4 | GO:0031584 | activation of phospholipase D activity(GO:0031584) |
0.1 | 1.9 | GO:0042789 | mRNA transcription from RNA polymerase II promoter(GO:0042789) |
0.1 | 0.6 | GO:0033489 | cholesterol biosynthetic process via desmosterol(GO:0033489) cholesterol biosynthetic process via lathosterol(GO:0033490) |
0.1 | 3.0 | GO:0006379 | mRNA cleavage(GO:0006379) |
0.1 | 2.0 | GO:0007130 | synaptonemal complex assembly(GO:0007130) |
0.1 | 12.3 | GO:1903509 | glycolipid metabolic process(GO:0006664) liposaccharide metabolic process(GO:1903509) |
0.1 | 1.6 | GO:0046329 | negative regulation of JNK cascade(GO:0046329) |
0.1 | 0.5 | GO:0030432 | peristalsis(GO:0030432) |
0.1 | 0.3 | GO:0046521 | sphingoid catabolic process(GO:0046521) |
0.1 | 0.2 | GO:0033008 | positive regulation of myeloid leukocyte mediated immunity(GO:0002888) positive regulation of mast cell activation involved in immune response(GO:0033008) positive regulation of mast cell degranulation(GO:0043306) |
0.1 | 1.0 | GO:0032688 | negative regulation of interferon-beta production(GO:0032688) |
0.1 | 1.6 | GO:0043011 | myeloid dendritic cell differentiation(GO:0043011) |
0.1 | 1.9 | GO:0048873 | homeostasis of number of cells within a tissue(GO:0048873) |
0.1 | 0.4 | GO:0002024 | diet induced thermogenesis(GO:0002024) |
0.1 | 5.5 | GO:0044243 | collagen catabolic process(GO:0030574) multicellular organism catabolic process(GO:0044243) |
0.1 | 1.8 | GO:0042475 | odontogenesis of dentin-containing tooth(GO:0042475) |
0.1 | 7.1 | GO:0030593 | neutrophil chemotaxis(GO:0030593) |
0.1 | 2.7 | GO:0016338 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules(GO:0016338) |
0.1 | 12.2 | GO:2000257 | regulation of complement activation(GO:0030449) regulation of protein activation cascade(GO:2000257) |
0.1 | 4.4 | GO:0003073 | regulation of systemic arterial blood pressure(GO:0003073) |
0.1 | 3.2 | GO:0036092 | phosphatidylinositol-3-phosphate biosynthetic process(GO:0036092) |
0.1 | 0.8 | GO:0097178 | ruffle assembly(GO:0097178) |
0.1 | 0.3 | GO:1904425 | negative regulation of GTP binding(GO:1904425) |
0.1 | 1.8 | GO:0007605 | sensory perception of sound(GO:0007605) |
0.1 | 1.9 | GO:0010811 | positive regulation of cell-substrate adhesion(GO:0010811) |
0.1 | 1.5 | GO:0070207 | protein homotrimerization(GO:0070207) |
0.1 | 4.3 | GO:0006636 | unsaturated fatty acid biosynthetic process(GO:0006636) |
0.1 | 0.4 | GO:0045861 | negative regulation of proteolysis(GO:0045861) |
0.1 | 1.3 | GO:0097120 | receptor localization to synapse(GO:0097120) |
0.1 | 6.2 | GO:0007219 | Notch signaling pathway(GO:0007219) |
0.1 | 4.8 | GO:0006901 | vesicle coating(GO:0006901) vesicle targeting, rough ER to cis-Golgi(GO:0048207) COPII vesicle coating(GO:0048208) |
0.1 | 0.3 | GO:1901906 | diadenosine polyphosphate catabolic process(GO:0015961) diphosphoinositol polyphosphate metabolic process(GO:0071543) diadenosine pentaphosphate metabolic process(GO:1901906) diadenosine pentaphosphate catabolic process(GO:1901907) diadenosine hexaphosphate metabolic process(GO:1901908) diadenosine hexaphosphate catabolic process(GO:1901909) adenosine 5'-(hexahydrogen pentaphosphate) metabolic process(GO:1901910) adenosine 5'-(hexahydrogen pentaphosphate) catabolic process(GO:1901911) |
0.1 | 0.7 | GO:0010991 | negative regulation of SMAD protein complex assembly(GO:0010991) |
0.1 | 1.0 | GO:0006590 | thyroid hormone generation(GO:0006590) |
0.1 | 7.4 | GO:0016197 | endosomal transport(GO:0016197) |
0.1 | 1.6 | GO:0048599 | oocyte development(GO:0048599) |
0.1 | 0.6 | GO:0010962 | regulation of glycogen biosynthetic process(GO:0005979) regulation of glucan biosynthetic process(GO:0010962) |
0.1 | 0.3 | GO:0061635 | regulation of protein complex stability(GO:0061635) |
0.1 | 5.8 | GO:0006805 | xenobiotic metabolic process(GO:0006805) |
0.0 | 8.0 | GO:0006469 | negative regulation of protein kinase activity(GO:0006469) |
0.0 | 0.6 | GO:0002431 | Fc receptor mediated stimulatory signaling pathway(GO:0002431) |
0.0 | 0.2 | GO:0035810 | positive regulation of urine volume(GO:0035810) |
0.0 | 1.8 | GO:0002576 | platelet degranulation(GO:0002576) |
0.0 | 2.2 | GO:0045540 | regulation of cholesterol biosynthetic process(GO:0045540) |
0.0 | 0.2 | GO:0097205 | glomerular filtration(GO:0003094) renal filtration(GO:0097205) |
0.0 | 0.4 | GO:0006069 | ethanol oxidation(GO:0006069) |
0.0 | 1.3 | GO:0006904 | vesicle docking involved in exocytosis(GO:0006904) |
0.0 | 1.5 | GO:0006305 | DNA alkylation(GO:0006305) DNA methylation(GO:0006306) |
0.0 | 1.9 | GO:0016525 | negative regulation of angiogenesis(GO:0016525) |
0.0 | 1.1 | GO:0007173 | epidermal growth factor receptor signaling pathway(GO:0007173) |
0.0 | 0.2 | GO:0032494 | response to peptidoglycan(GO:0032494) |
0.0 | 0.2 | GO:1990573 | potassium ion import across plasma membrane(GO:1990573) |
0.0 | 0.3 | GO:0090398 | cellular senescence(GO:0090398) |
0.0 | 2.6 | GO:0007586 | digestion(GO:0007586) |
0.0 | 5.4 | GO:0051260 | protein homooligomerization(GO:0051260) |
0.0 | 0.5 | GO:0035725 | sodium ion transmembrane transport(GO:0035725) |
0.0 | 0.3 | GO:0035411 | catenin import into nucleus(GO:0035411) |
0.0 | 2.6 | GO:0007160 | cell-matrix adhesion(GO:0007160) |
0.0 | 0.4 | GO:0035264 | multicellular organism growth(GO:0035264) |
0.0 | 0.1 | GO:0048747 | muscle fiber development(GO:0048747) |
0.0 | 0.2 | GO:0031102 | neuron projection regeneration(GO:0031102) |
0.0 | 0.1 | GO:0000305 | response to oxygen radical(GO:0000305) |
0.0 | 1.0 | GO:0030203 | glycosaminoglycan metabolic process(GO:0030203) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
13.4 | 40.3 | GO:0038039 | G-protein coupled receptor heterodimeric complex(GO:0038039) |
8.9 | 35.8 | GO:0031838 | haptoglobin-hemoglobin complex(GO:0031838) |
8.1 | 40.7 | GO:0048787 | presynaptic active zone membrane(GO:0048787) |
7.1 | 28.4 | GO:0031673 | H zone(GO:0031673) |
6.9 | 27.7 | GO:0016533 | cyclin-dependent protein kinase 5 holoenzyme complex(GO:0016533) |
6.7 | 20.0 | GO:0019034 | viral replication complex(GO:0019034) |
6.0 | 36.1 | GO:0031232 | extrinsic component of external side of plasma membrane(GO:0031232) |
5.2 | 15.7 | GO:0097058 | CRLF-CLCF1 complex(GO:0097058) |
5.0 | 34.9 | GO:0033269 | internode region of axon(GO:0033269) |
4.8 | 38.4 | GO:0098845 | postsynaptic endosome(GO:0098845) |
4.8 | 28.8 | GO:0030991 | intraciliary transport particle A(GO:0030991) |
4.3 | 12.9 | GO:0044352 | pinosome(GO:0044352) macropinosome(GO:0044354) |
4.2 | 71.0 | GO:0001518 | voltage-gated sodium channel complex(GO:0001518) |
4.0 | 87.6 | GO:0032591 | dendritic spine membrane(GO:0032591) |
3.7 | 78.0 | GO:0044295 | axonal growth cone(GO:0044295) |
3.3 | 23.0 | GO:0061700 | GATOR2 complex(GO:0061700) |
3.1 | 6.3 | GO:0070381 | endosome to plasma membrane transport vesicle(GO:0070381) |
3.1 | 18.5 | GO:0009331 | glycerol-3-phosphate dehydrogenase complex(GO:0009331) |
3.0 | 9.1 | GO:0031251 | PAN complex(GO:0031251) |
3.0 | 18.1 | GO:0005927 | muscle tendon junction(GO:0005927) |
2.9 | 35.0 | GO:0043190 | ATP-binding cassette (ABC) transporter complex(GO:0043190) |
2.5 | 9.9 | GO:0031417 | NatC complex(GO:0031417) |
2.4 | 16.7 | GO:0044326 | dendritic spine neck(GO:0044326) |
2.4 | 31.0 | GO:1990454 | L-type voltage-gated calcium channel complex(GO:1990454) |
2.3 | 18.7 | GO:0060203 | clathrin-sculpted glutamate transport vesicle(GO:0060199) clathrin-sculpted glutamate transport vesicle membrane(GO:0060203) |
2.3 | 254.2 | GO:0005905 | clathrin-coated pit(GO:0005905) |
2.3 | 9.0 | GO:0070695 | FHF complex(GO:0070695) |
2.2 | 4.4 | GO:0044308 | axonal spine(GO:0044308) |
2.2 | 17.5 | GO:0031083 | BLOC-1 complex(GO:0031083) |
2.1 | 8.5 | GO:0000333 | telomerase catalytic core complex(GO:0000333) |
2.1 | 12.3 | GO:1990682 | CSF1-CSF1R complex(GO:1990682) |
2.0 | 8.2 | GO:0033596 | TSC1-TSC2 complex(GO:0033596) |
1.9 | 5.7 | GO:0005953 | CAAX-protein geranylgeranyltransferase complex(GO:0005953) |
1.9 | 26.4 | GO:0016461 | unconventional myosin complex(GO:0016461) |
1.9 | 13.1 | GO:0000813 | ESCRT I complex(GO:0000813) |
1.9 | 9.3 | GO:0030130 | clathrin coat of trans-Golgi network vesicle(GO:0030130) |
1.8 | 7.3 | GO:1990246 | uniplex complex(GO:1990246) |
1.8 | 12.8 | GO:0070852 | cell body fiber(GO:0070852) |
1.8 | 27.0 | GO:0030877 | beta-catenin destruction complex(GO:0030877) |
1.8 | 21.5 | GO:0031362 | anchored component of external side of plasma membrane(GO:0031362) |
1.7 | 9.9 | GO:0065010 | extracellular membrane-bounded organelle(GO:0065010) |
1.5 | 119.4 | GO:0030672 | synaptic vesicle membrane(GO:0030672) exocytic vesicle membrane(GO:0099501) |
1.5 | 7.5 | GO:0008622 | epsilon DNA polymerase complex(GO:0008622) |
1.5 | 11.9 | GO:0005683 | U7 snRNP(GO:0005683) |
1.5 | 37.1 | GO:0008074 | guanylate cyclase complex, soluble(GO:0008074) |
1.4 | 2.8 | GO:0000125 | PCAF complex(GO:0000125) |
1.4 | 7.1 | GO:0008275 | gamma-tubulin small complex(GO:0008275) |
1.4 | 38.2 | GO:0043218 | compact myelin(GO:0043218) |
1.3 | 26.7 | GO:0005952 | cAMP-dependent protein kinase complex(GO:0005952) |
1.3 | 18.5 | GO:0043194 | axon initial segment(GO:0043194) |
1.3 | 6.6 | GO:0036398 | TCR signalosome(GO:0036398) |
1.3 | 11.7 | GO:0099634 | postsynaptic specialization membrane(GO:0099634) |
1.3 | 23.9 | GO:0097381 | photoreceptor disc membrane(GO:0097381) |
1.2 | 53.3 | GO:1904115 | axon cytoplasm(GO:1904115) |
1.2 | 11.0 | GO:0097427 | microtubule bundle(GO:0097427) |
1.2 | 3.6 | GO:0060187 | cell pole(GO:0060187) |
1.2 | 31.3 | GO:0051233 | spindle midzone(GO:0051233) |
1.1 | 9.1 | GO:0031462 | Cul2-RING ubiquitin ligase complex(GO:0031462) |
1.1 | 20.4 | GO:0031089 | platelet dense granule lumen(GO:0031089) |
1.1 | 11.1 | GO:0031045 | dense core granule(GO:0031045) |
1.1 | 16.5 | GO:0030478 | actin cap(GO:0030478) |
1.1 | 11.7 | GO:0033391 | chromatoid body(GO:0033391) |
1.1 | 12.6 | GO:0032045 | guanyl-nucleotide exchange factor complex(GO:0032045) |
1.0 | 17.8 | GO:0071782 | endoplasmic reticulum tubular network(GO:0071782) |
1.0 | 31.4 | GO:0090545 | NuRD complex(GO:0016581) CHD-type complex(GO:0090545) |
1.0 | 7.2 | GO:0045252 | oxoglutarate dehydrogenase complex(GO:0045252) |
1.0 | 49.4 | GO:0033017 | sarcoplasmic reticulum membrane(GO:0033017) |
1.0 | 3.9 | GO:0014731 | spectrin-associated cytoskeleton(GO:0014731) |
0.9 | 2.7 | GO:1990851 | Wnt-Frizzled-LRP5/6 complex(GO:1990851) |
0.9 | 12.6 | GO:0035102 | PRC1 complex(GO:0035102) |
0.9 | 7.7 | GO:0042567 | insulin-like growth factor ternary complex(GO:0042567) |
0.8 | 58.1 | GO:0043195 | terminal bouton(GO:0043195) |
0.8 | 4.2 | GO:0035859 | Seh1-associated complex(GO:0035859) Iml1 complex(GO:1990130) |
0.8 | 20.8 | GO:0034362 | low-density lipoprotein particle(GO:0034362) |
0.8 | 28.7 | GO:0005891 | voltage-gated calcium channel complex(GO:0005891) |
0.8 | 3.9 | GO:0005594 | collagen type IX trimer(GO:0005594) |
0.8 | 4.6 | GO:0005958 | DNA-dependent protein kinase-DNA ligase 4 complex(GO:0005958) DNA ligase IV complex(GO:0032807) |
0.8 | 15.2 | GO:0071565 | nBAF complex(GO:0071565) |
0.8 | 4.5 | GO:0001939 | female pronucleus(GO:0001939) |
0.7 | 4.4 | GO:0097129 | cyclin D2-CDK4 complex(GO:0097129) |
0.7 | 9.4 | GO:0031209 | SCAR complex(GO:0031209) |
0.7 | 36.7 | GO:0005834 | heterotrimeric G-protein complex(GO:0005834) |
0.7 | 6.4 | GO:0005964 | phosphorylase kinase complex(GO:0005964) |
0.7 | 4.1 | GO:0070775 | H3 histone acetyltransferase complex(GO:0070775) MOZ/MORF histone acetyltransferase complex(GO:0070776) |
0.7 | 20.3 | GO:0030057 | desmosome(GO:0030057) |
0.7 | 14.6 | GO:0097440 | apical dendrite(GO:0097440) |
0.6 | 25.2 | GO:0030669 | clathrin-coated endocytic vesicle membrane(GO:0030669) |
0.6 | 3.2 | GO:0034366 | spherical high-density lipoprotein particle(GO:0034366) |
0.6 | 2.5 | GO:1990578 | perinuclear endoplasmic reticulum membrane(GO:1990578) |
0.6 | 3.6 | GO:0032311 | angiogenin-PRI complex(GO:0032311) |
0.6 | 13.9 | GO:0071141 | SMAD protein complex(GO:0071141) |
0.6 | 3.0 | GO:0031313 | extrinsic component of endosome membrane(GO:0031313) |
0.6 | 7.6 | GO:0008091 | spectrin(GO:0008091) |
0.6 | 6.8 | GO:0005642 | annulate lamellae(GO:0005642) |
0.6 | 5.1 | GO:0034464 | BBSome(GO:0034464) |
0.6 | 9.5 | GO:0046658 | anchored component of plasma membrane(GO:0046658) |
0.6 | 12.2 | GO:0031527 | filopodium membrane(GO:0031527) |
0.5 | 40.0 | GO:0042734 | presynaptic membrane(GO:0042734) |
0.5 | 1.6 | GO:0005960 | glycine cleavage complex(GO:0005960) |
0.5 | 43.8 | GO:0070382 | exocytic vesicle(GO:0070382) |
0.5 | 16.3 | GO:0001917 | photoreceptor inner segment(GO:0001917) |
0.5 | 4.2 | GO:0043219 | lateral loop(GO:0043219) |
0.5 | 7.8 | GO:0005869 | dynactin complex(GO:0005869) |
0.5 | 1.9 | GO:0055087 | Ski complex(GO:0055087) |
0.5 | 44.8 | GO:0008076 | voltage-gated potassium channel complex(GO:0008076) potassium channel complex(GO:0034705) |
0.5 | 26.4 | GO:0097610 | cleavage furrow(GO:0032154) cell surface furrow(GO:0097610) |
0.5 | 8.1 | GO:0030119 | AP-type membrane coat adaptor complex(GO:0030119) |
0.5 | 1.0 | GO:0031201 | SNARE complex(GO:0031201) |
0.5 | 6.2 | GO:0042555 | MCM complex(GO:0042555) |
0.5 | 15.9 | GO:0090665 | dystrophin-associated glycoprotein complex(GO:0016010) glycoprotein complex(GO:0090665) |
0.5 | 5.1 | GO:0036513 | Derlin-1 retrotranslocation complex(GO:0036513) |
0.5 | 3.7 | GO:0030665 | clathrin-coated vesicle membrane(GO:0030665) |
0.5 | 12.8 | GO:0005868 | cytoplasmic dynein complex(GO:0005868) |
0.4 | 29.8 | GO:0031463 | Cul3-RING ubiquitin ligase complex(GO:0031463) |
0.4 | 95.1 | GO:0060076 | excitatory synapse(GO:0060076) |
0.4 | 43.0 | GO:0032587 | ruffle membrane(GO:0032587) |
0.4 | 4.1 | GO:0045180 | basal cortex(GO:0045180) |
0.4 | 1.9 | GO:0071008 | U2-type post-mRNA release spliceosomal complex(GO:0071008) |
0.4 | 16.8 | GO:0005865 | striated muscle thin filament(GO:0005865) |
0.4 | 6.4 | GO:0005885 | Arp2/3 protein complex(GO:0005885) |
0.4 | 36.4 | GO:0031234 | extrinsic component of cytoplasmic side of plasma membrane(GO:0031234) |
0.4 | 15.0 | GO:0014704 | intercalated disc(GO:0014704) |
0.4 | 5.0 | GO:0036038 | MKS complex(GO:0036038) |
0.4 | 42.5 | GO:0031225 | anchored component of membrane(GO:0031225) |
0.3 | 38.2 | GO:0031901 | early endosome membrane(GO:0031901) |
0.3 | 2.4 | GO:0005614 | interstitial matrix(GO:0005614) |
0.3 | 4.6 | GO:0032590 | dendrite membrane(GO:0032590) |
0.3 | 2.0 | GO:0097197 | tetraspanin-enriched microdomain(GO:0097197) |
0.3 | 4.8 | GO:0031235 | intrinsic component of the cytoplasmic side of the plasma membrane(GO:0031235) |
0.3 | 3.5 | GO:0002116 | semaphorin receptor complex(GO:0002116) |
0.3 | 2.1 | GO:0030870 | Mre11 complex(GO:0030870) |
0.3 | 5.5 | GO:0005942 | phosphatidylinositol 3-kinase complex(GO:0005942) |
0.3 | 2.4 | GO:0005587 | collagen type IV trimer(GO:0005587) |
0.3 | 20.8 | GO:0001726 | ruffle(GO:0001726) |
0.3 | 4.3 | GO:0031229 | integral component of nuclear inner membrane(GO:0005639) intrinsic component of nuclear inner membrane(GO:0031229) nuclear membrane part(GO:0044453) |
0.3 | 9.1 | GO:0005902 | microvillus(GO:0005902) |
0.3 | 8.1 | GO:0005605 | basal lamina(GO:0005605) |
0.3 | 2.5 | GO:0008024 | cyclin/CDK positive transcription elongation factor complex(GO:0008024) |
0.3 | 7.7 | GO:0031256 | leading edge membrane(GO:0031256) |
0.3 | 28.0 | GO:0031253 | cell projection membrane(GO:0031253) |
0.3 | 9.0 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
0.3 | 8.7 | GO:0055037 | recycling endosome(GO:0055037) |
0.3 | 6.4 | GO:0055038 | recycling endosome membrane(GO:0055038) |
0.2 | 3.0 | GO:0005922 | connexon complex(GO:0005922) |
0.2 | 9.1 | GO:0016592 | mediator complex(GO:0016592) |
0.2 | 37.1 | GO:0001650 | fibrillar center(GO:0001650) |
0.2 | 2.6 | GO:0016602 | CCAAT-binding factor complex(GO:0016602) |
0.2 | 13.8 | GO:0005604 | basement membrane(GO:0005604) |
0.2 | 5.0 | GO:0031307 | integral component of mitochondrial outer membrane(GO:0031307) |
0.2 | 5.2 | GO:0009925 | basal plasma membrane(GO:0009925) |
0.2 | 15.4 | GO:0019898 | extrinsic component of membrane(GO:0019898) |
0.2 | 14.8 | GO:0005581 | collagen trimer(GO:0005581) |
0.2 | 2.2 | GO:0030175 | filopodium(GO:0030175) |
0.2 | 1.1 | GO:0002193 | MAML1-RBP-Jkappa- ICN1 complex(GO:0002193) |
0.2 | 3.4 | GO:0031594 | neuromuscular junction(GO:0031594) |
0.2 | 11.7 | GO:0005782 | peroxisomal matrix(GO:0005782) microbody lumen(GO:0031907) |
0.2 | 18.1 | GO:0005814 | centriole(GO:0005814) |
0.2 | 1.3 | GO:0060077 | inhibitory synapse(GO:0060077) |
0.2 | 9.8 | GO:0098793 | presynapse(GO:0098793) |
0.2 | 4.6 | GO:0044322 | endoplasmic reticulum quality control compartment(GO:0044322) |
0.2 | 11.1 | GO:0000792 | heterochromatin(GO:0000792) |
0.2 | 3.8 | GO:0005901 | caveola(GO:0005901) plasma membrane raft(GO:0044853) |
0.2 | 1.7 | GO:0005652 | nuclear lamina(GO:0005652) |
0.2 | 0.5 | GO:0032009 | early phagosome(GO:0032009) |
0.1 | 2.9 | GO:0031231 | integral component of peroxisomal membrane(GO:0005779) intrinsic component of peroxisomal membrane(GO:0031231) |
0.1 | 1.8 | GO:0030127 | COPII vesicle coat(GO:0030127) |
0.1 | 1.3 | GO:0034385 | very-low-density lipoprotein particle(GO:0034361) triglyceride-rich lipoprotein particle(GO:0034385) |
0.1 | 4.3 | GO:0071339 | MLL1/2 complex(GO:0044665) MLL1 complex(GO:0071339) |
0.1 | 2.3 | GO:0005801 | cis-Golgi network(GO:0005801) |
0.1 | 18.4 | GO:0010008 | endosome membrane(GO:0010008) |
0.1 | 6.1 | GO:0015030 | Cajal body(GO:0015030) |
0.1 | 10.1 | GO:0045177 | apical part of cell(GO:0045177) |
0.1 | 9.7 | GO:0005923 | bicellular tight junction(GO:0005923) |
0.1 | 2.1 | GO:0002080 | acrosomal membrane(GO:0002080) |
0.1 | 1.0 | GO:0032839 | dendrite cytoplasm(GO:0032839) |
0.1 | 21.5 | GO:0005788 | endoplasmic reticulum lumen(GO:0005788) |
0.1 | 5.5 | GO:0005796 | Golgi lumen(GO:0005796) |
0.1 | 9.2 | GO:0031514 | motile cilium(GO:0031514) |
0.1 | 9.3 | GO:0031093 | platelet alpha granule lumen(GO:0031093) |
0.1 | 0.1 | GO:0016942 | insulin-like growth factor binding protein complex(GO:0016942) growth factor complex(GO:0036454) |
0.1 | 4.2 | GO:0043204 | perikaryon(GO:0043204) |
0.1 | 2.2 | GO:0005637 | nuclear inner membrane(GO:0005637) |
0.1 | 0.9 | GO:0032580 | Golgi cisterna membrane(GO:0032580) |
0.1 | 98.5 | GO:0005887 | integral component of plasma membrane(GO:0005887) |
0.1 | 2.4 | GO:0044438 | microbody part(GO:0044438) peroxisomal part(GO:0044439) |
0.1 | 1.9 | GO:0001533 | cornified envelope(GO:0001533) |
0.0 | 0.4 | GO:0000506 | glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex(GO:0000506) |
0.0 | 1.5 | GO:0101003 | ficolin-1-rich granule membrane(GO:0101003) |
0.0 | 0.6 | GO:0000164 | protein phosphatase type 1 complex(GO:0000164) |
0.0 | 0.5 | GO:0001673 | male germ cell nucleus(GO:0001673) |
0.0 | 0.9 | GO:0035145 | exon-exon junction complex(GO:0035145) |
0.0 | 0.3 | GO:0030008 | TRAPP complex(GO:0030008) |
0.0 | 0.6 | GO:0008180 | COP9 signalosome(GO:0008180) |
0.0 | 51.6 | GO:0016021 | integral component of membrane(GO:0016021) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
23.7 | 71.0 | GO:0086062 | voltage-gated sodium channel activity involved in Purkinje myocyte action potential(GO:0086062) |
15.3 | 45.8 | GO:0016838 | carbon-oxygen lyase activity, acting on phosphates(GO:0016838) |
13.4 | 40.3 | GO:0004965 | G-protein coupled GABA receptor activity(GO:0004965) |
9.2 | 27.7 | GO:0016534 | cyclin-dependent protein kinase 5 activator activity(GO:0016534) |
8.2 | 8.2 | GO:0032794 | GTPase activating protein binding(GO:0032794) |
8.1 | 32.2 | GO:0043812 | phosphatidylinositol-4-phosphate phosphatase activity(GO:0043812) |
7.3 | 22.0 | GO:0032184 | SUMO polymer binding(GO:0032184) |
7.0 | 28.0 | GO:0004782 | sulfinoalanine decarboxylase activity(GO:0004782) |
6.6 | 19.9 | GO:0015018 | galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase activity(GO:0015018) |
6.5 | 19.6 | GO:0047273 | galactosylgalactosylglucosylceramide beta-D-acetylgalactosaminyltransferase activity(GO:0047273) |
6.2 | 31.0 | GO:0052833 | inositol monophosphate 1-phosphatase activity(GO:0008934) inositol monophosphate 3-phosphatase activity(GO:0052832) inositol monophosphate 4-phosphatase activity(GO:0052833) inositol monophosphate phosphatase activity(GO:0052834) |
6.1 | 18.4 | GO:0004938 | alpha2-adrenergic receptor activity(GO:0004938) |
6.0 | 18.1 | GO:0035403 | histone kinase activity (H3-T6 specific)(GO:0035403) |
5.6 | 16.9 | GO:0004157 | dihydropyrimidinase activity(GO:0004157) |
5.5 | 21.8 | GO:0004803 | transposase activity(GO:0004803) |
5.4 | 32.4 | GO:0008597 | calcium-dependent protein serine/threonine phosphatase regulator activity(GO:0008597) |
5.3 | 5.3 | GO:0030226 | apolipoprotein receptor activity(GO:0030226) |
5.3 | 21.1 | GO:0047391 | alkylglycerophosphoethanolamine phosphodiesterase activity(GO:0047391) |
5.2 | 15.7 | GO:0015218 | pyrimidine nucleotide transmembrane transporter activity(GO:0015218) |
5.0 | 19.8 | GO:0031685 | adenosine receptor binding(GO:0031685) |
4.8 | 19.4 | GO:0047288 | monosialoganglioside sialyltransferase activity(GO:0047288) |
4.7 | 23.7 | GO:0070728 | leucine binding(GO:0070728) |
4.7 | 18.7 | GO:0015319 | sodium:inorganic phosphate symporter activity(GO:0015319) |
4.3 | 17.1 | GO:0061628 | H3K27me3 modified histone binding(GO:0061628) |
4.3 | 51.2 | GO:0019911 | structural constituent of myelin sheath(GO:0019911) |
4.3 | 12.8 | GO:0047751 | 3-oxo-5-alpha-steroid 4-dehydrogenase activity(GO:0003865) steroid dehydrogenase activity, acting on the CH-CH group of donors(GO:0033765) cholestenone 5-alpha-reductase activity(GO:0047751) |
4.3 | 21.3 | GO:0008420 | CTD phosphatase activity(GO:0008420) |
4.2 | 37.4 | GO:0032051 | clathrin light chain binding(GO:0032051) |
4.0 | 11.9 | GO:0071209 | U7 snRNA binding(GO:0071209) |
3.9 | 23.4 | GO:0004800 | thyroxine 5'-deiodinase activity(GO:0004800) |
3.9 | 89.4 | GO:0005545 | 1-phosphatidylinositol binding(GO:0005545) |
3.7 | 3.7 | GO:0016401 | palmitoyl-CoA oxidase activity(GO:0016401) |
3.6 | 14.5 | GO:0015057 | thrombin receptor activity(GO:0015057) |
3.6 | 21.5 | GO:1903135 | cupric ion binding(GO:1903135) |
3.6 | 28.5 | GO:0035374 | chondroitin sulfate binding(GO:0035374) |
3.5 | 17.4 | GO:0004703 | G-protein coupled receptor kinase activity(GO:0004703) |
3.4 | 37.9 | GO:0031681 | G-protein beta-subunit binding(GO:0031681) |
3.4 | 92.1 | GO:0050780 | dopamine receptor binding(GO:0050780) |
3.4 | 10.2 | GO:0050211 | procollagen galactosyltransferase activity(GO:0050211) |
3.4 | 16.9 | GO:0070097 | delta-catenin binding(GO:0070097) |
3.3 | 13.3 | GO:0004449 | isocitrate dehydrogenase (NAD+) activity(GO:0004449) |
3.3 | 13.2 | GO:0033829 | O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase activity(GO:0033829) |
3.2 | 12.9 | GO:0004706 | JUN kinase kinase kinase activity(GO:0004706) |
3.2 | 19.2 | GO:0003998 | acylphosphatase activity(GO:0003998) |
3.2 | 31.8 | GO:0005007 | fibroblast growth factor-activated receptor activity(GO:0005007) |
3.2 | 9.5 | GO:0004488 | methenyltetrahydrofolate cyclohydrolase activity(GO:0004477) methylenetetrahydrofolate dehydrogenase (NAD+) activity(GO:0004487) methylenetetrahydrofolate dehydrogenase (NADP+) activity(GO:0004488) |
3.1 | 15.7 | GO:0005127 | ciliary neurotrophic factor receptor binding(GO:0005127) |
3.1 | 12.6 | GO:0070815 | peptidyl-lysine 5-dioxygenase activity(GO:0070815) |
3.1 | 9.4 | GO:0098519 | nucleotide phosphatase activity, acting on free nucleotides(GO:0098519) |
3.1 | 18.8 | GO:0004741 | [pyruvate dehydrogenase (lipoamide)] phosphatase activity(GO:0004741) |
3.0 | 15.2 | GO:0004994 | somatostatin receptor activity(GO:0004994) |
3.0 | 14.9 | GO:0004591 | oxoglutarate dehydrogenase (succinyl-transferring) activity(GO:0004591) |
3.0 | 14.9 | GO:0004489 | methylenetetrahydrofolate reductase (NAD(P)H) activity(GO:0004489) |
2.8 | 8.5 | GO:0003968 | RNA-directed RNA polymerase activity(GO:0003968) |
2.8 | 35.8 | GO:0005344 | oxygen transporter activity(GO:0005344) |
2.7 | 8.1 | GO:0016812 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides(GO:0016812) |
2.7 | 8.0 | GO:0035501 | MH1 domain binding(GO:0035501) |
2.6 | 13.2 | GO:0016403 | dimethylargininase activity(GO:0016403) |
2.6 | 10.4 | GO:0005222 | intracellular cAMP activated cation channel activity(GO:0005222) |
2.5 | 34.5 | GO:0017162 | aryl hydrocarbon receptor binding(GO:0017162) |
2.4 | 17.0 | GO:0050682 | AF-2 domain binding(GO:0050682) |
2.4 | 7.3 | GO:0052831 | inositol tetrakisphosphate 1-kinase activity(GO:0047325) inositol tetrakisphosphate kinase activity(GO:0051765) inositol-1,3,4-trisphosphate 6-kinase activity(GO:0052725) inositol-1,3,4-trisphosphate 5-kinase activity(GO:0052726) inositol-1,3,4,5,6-pentakisphosphate 1-phosphatase activity(GO:0052825) inositol-1,3,4,6-tetrakisphosphate 6-phosphatase activity(GO:0052830) inositol-1,3,4,6-tetrakisphosphate 1-phosphatase activity(GO:0052831) inositol-3,4,6-trisphosphate 1-kinase activity(GO:0052835) |
2.4 | 9.4 | GO:0008940 | nitrate reductase activity(GO:0008940) |
2.4 | 4.7 | GO:0005168 | neurotrophin TRKA receptor binding(GO:0005168) |
2.3 | 30.5 | GO:0031005 | filamin binding(GO:0031005) |
2.3 | 11.7 | GO:0010465 | nerve growth factor receptor activity(GO:0010465) |
2.3 | 9.0 | GO:0050262 | ribosylnicotinamide kinase activity(GO:0050262) ribosylnicotinate kinase activity(GO:0061769) |
2.3 | 13.5 | GO:0048039 | ubiquinone binding(GO:0048039) |
2.2 | 29.0 | GO:0097371 | MDM2/MDM4 family protein binding(GO:0097371) |
2.1 | 12.9 | GO:0004430 | 1-phosphatidylinositol 4-kinase activity(GO:0004430) |
2.1 | 36.1 | GO:0008432 | JUN kinase binding(GO:0008432) |
2.1 | 8.5 | GO:0060422 | peptidyl-dipeptidase inhibitor activity(GO:0060422) |
2.1 | 16.5 | GO:0036312 | phosphatidylinositol 3-kinase regulatory subunit binding(GO:0036312) |
2.1 | 12.3 | GO:0005157 | macrophage colony-stimulating factor receptor binding(GO:0005157) |
2.0 | 20.2 | GO:0009374 | biotin binding(GO:0009374) |
2.0 | 19.6 | GO:0004445 | inositol-polyphosphate 5-phosphatase activity(GO:0004445) |
1.9 | 15.4 | GO:0047144 | 2-acylglycerol-3-phosphate O-acyltransferase activity(GO:0047144) |
1.9 | 11.5 | GO:0016015 | morphogen activity(GO:0016015) |
1.9 | 11.4 | GO:0043237 | laminin-1 binding(GO:0043237) |
1.9 | 5.7 | GO:0004662 | CAAX-protein geranylgeranyltransferase activity(GO:0004662) |
1.9 | 11.3 | GO:0015185 | gamma-aminobutyric acid:sodium symporter activity(GO:0005332) gamma-aminobutyric acid transmembrane transporter activity(GO:0015185) |
1.9 | 7.4 | GO:0004980 | melanocyte-stimulating hormone receptor activity(GO:0004980) |
1.9 | 20.4 | GO:0086007 | voltage-gated calcium channel activity involved in cardiac muscle cell action potential(GO:0086007) |
1.9 | 51.8 | GO:0017075 | syntaxin-1 binding(GO:0017075) |
1.8 | 10.9 | GO:0030618 | transforming growth factor beta receptor, pathway-specific cytoplasmic mediator activity(GO:0030618) |
1.8 | 45.1 | GO:0004012 | phospholipid-translocating ATPase activity(GO:0004012) |
1.8 | 21.5 | GO:0010385 | double-stranded methylated DNA binding(GO:0010385) |
1.8 | 24.9 | GO:0004723 | calcium-dependent protein serine/threonine phosphatase activity(GO:0004723) |
1.8 | 7.0 | GO:0004505 | phenylalanine 4-monooxygenase activity(GO:0004505) |
1.8 | 5.3 | GO:0008321 | Ral guanyl-nucleotide exchange factor activity(GO:0008321) |
1.7 | 12.0 | GO:0045159 | myosin II binding(GO:0045159) |
1.7 | 10.2 | GO:0008467 | [heparan sulfate]-glucosamine 3-sulfotransferase 1 activity(GO:0008467) |
1.7 | 5.0 | GO:0070984 | SET domain binding(GO:0070984) |
1.6 | 6.6 | GO:0004963 | follicle-stimulating hormone receptor activity(GO:0004963) |
1.6 | 1.6 | GO:0004924 | oncostatin-M receptor activity(GO:0004924) |
1.6 | 6.5 | GO:0008410 | CoA-transferase activity(GO:0008410) |
1.6 | 47.2 | GO:0003887 | DNA-directed DNA polymerase activity(GO:0003887) |
1.6 | 15.6 | GO:0001730 | 2'-5'-oligoadenylate synthetase activity(GO:0001730) |
1.6 | 14.0 | GO:0016813 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines(GO:0016813) |
1.5 | 4.6 | GO:0004103 | choline kinase activity(GO:0004103) |
1.5 | 32.1 | GO:0005112 | Notch binding(GO:0005112) |
1.5 | 4.6 | GO:0003980 | UDP-glucose:glycoprotein glucosyltransferase activity(GO:0003980) |
1.5 | 51.4 | GO:0030742 | GTP-dependent protein binding(GO:0030742) |
1.5 | 37.1 | GO:0004383 | guanylate cyclase activity(GO:0004383) |
1.5 | 30.8 | GO:0030552 | cAMP binding(GO:0030552) |
1.5 | 7.3 | GO:0046974 | histone methyltransferase activity (H3-K9 specific)(GO:0046974) |
1.4 | 9.9 | GO:0004035 | alkaline phosphatase activity(GO:0004035) |
1.4 | 4.2 | GO:0004999 | vasoactive intestinal polypeptide receptor activity(GO:0004999) |
1.4 | 9.8 | GO:0043533 | inositol 1,3,4,5 tetrakisphosphate binding(GO:0043533) |
1.4 | 52.8 | GO:0004115 | 3',5'-cyclic-AMP phosphodiesterase activity(GO:0004115) |
1.4 | 6.9 | GO:0060175 | brain-derived neurotrophic factor-activated receptor activity(GO:0060175) |
1.4 | 17.6 | GO:0070700 | BMP receptor binding(GO:0070700) |
1.3 | 6.7 | GO:0015307 | drug:proton antiporter activity(GO:0015307) |
1.3 | 2.7 | GO:0047760 | butyrate-CoA ligase activity(GO:0047760) |
1.3 | 61.2 | GO:0003785 | actin monomer binding(GO:0003785) |
1.3 | 37.2 | GO:0004708 | MAP kinase kinase activity(GO:0004708) |
1.3 | 8.0 | GO:0004169 | dolichyl-phosphate-mannose-protein mannosyltransferase activity(GO:0004169) |
1.3 | 15.8 | GO:0038036 | sphingosine-1-phosphate receptor activity(GO:0038036) |
1.3 | 13.1 | GO:0032036 | myosin heavy chain binding(GO:0032036) |
1.3 | 16.9 | GO:0046527 | glucosyltransferase activity(GO:0046527) |
1.3 | 6.4 | GO:0004689 | phosphorylase kinase activity(GO:0004689) |
1.3 | 8.9 | GO:0015277 | kainate selective glutamate receptor activity(GO:0015277) |
1.3 | 3.8 | GO:0016603 | glutaminyl-peptide cyclotransferase activity(GO:0016603) |
1.3 | 11.4 | GO:0008526 | phosphatidylinositol transporter activity(GO:0008526) |
1.3 | 22.6 | GO:0005522 | profilin binding(GO:0005522) |
1.3 | 12.5 | GO:0022841 | potassium ion leak channel activity(GO:0022841) |
1.2 | 26.0 | GO:0050321 | tau-protein kinase activity(GO:0050321) |
1.2 | 12.2 | GO:0016176 | superoxide-generating NADPH oxidase activator activity(GO:0016176) |
1.2 | 4.9 | GO:0032795 | heterotrimeric G-protein binding(GO:0032795) |
1.2 | 19.4 | GO:0030306 | ADP-ribosylation factor binding(GO:0030306) |
1.2 | 7.2 | GO:0050291 | sphingosine N-acyltransferase activity(GO:0050291) |
1.2 | 25.1 | GO:0030955 | potassium ion binding(GO:0030955) |
1.2 | 15.5 | GO:0047555 | 3',5'-cyclic-GMP phosphodiesterase activity(GO:0047555) |
1.2 | 54.5 | GO:0046875 | ephrin receptor binding(GO:0046875) |
1.2 | 3.5 | GO:0008424 | glycoprotein 6-alpha-L-fucosyltransferase activity(GO:0008424) alpha-(1->6)-fucosyltransferase activity(GO:0046921) |
1.2 | 11.8 | GO:0043236 | laminin binding(GO:0043236) |
1.1 | 9.0 | GO:0051959 | dynein light intermediate chain binding(GO:0051959) |
1.1 | 49.5 | GO:0030507 | spectrin binding(GO:0030507) |
1.1 | 6.7 | GO:0032558 | adenyl deoxyribonucleotide binding(GO:0032558) dATP binding(GO:0032564) |
1.1 | 6.6 | GO:0004522 | ribonuclease A activity(GO:0004522) |
1.1 | 8.8 | GO:0048495 | Roundabout binding(GO:0048495) |
1.1 | 29.5 | GO:0005159 | insulin-like growth factor receptor binding(GO:0005159) |
1.1 | 8.7 | GO:0005534 | galactose binding(GO:0005534) |
1.1 | 24.4 | GO:0042813 | Wnt-activated receptor activity(GO:0042813) |
1.1 | 5.3 | GO:0044736 | acid-sensing ion channel activity(GO:0044736) |
1.1 | 3.2 | GO:0102007 | lactonohydrolase activity(GO:0046573) acyl-L-homoserine-lactone lactonohydrolase activity(GO:0102007) |
1.1 | 28.4 | GO:0051010 | microtubule plus-end binding(GO:0051010) |
1.0 | 7.2 | GO:0017002 | activin-activated receptor activity(GO:0017002) |
1.0 | 10.1 | GO:0005094 | Rho GDP-dissociation inhibitor activity(GO:0005094) |
1.0 | 10.9 | GO:0015379 | potassium:chloride symporter activity(GO:0015379) potassium ion symporter activity(GO:0022820) |
1.0 | 4.9 | GO:0016402 | pristanoyl-CoA oxidase activity(GO:0016402) |
1.0 | 18.5 | GO:0048156 | tau protein binding(GO:0048156) |
1.0 | 9.7 | GO:0046870 | cadmium ion binding(GO:0046870) |
1.0 | 13.5 | GO:0015271 | outward rectifier potassium channel activity(GO:0015271) |
1.0 | 3.8 | GO:0048763 | calcium-induced calcium release activity(GO:0048763) |
1.0 | 6.7 | GO:0015440 | peptide-transporting ATPase activity(GO:0015440) |
0.9 | 26.6 | GO:0008157 | protein phosphatase 1 binding(GO:0008157) |
0.9 | 21.8 | GO:0030676 | Rac guanyl-nucleotide exchange factor activity(GO:0030676) |
0.9 | 7.5 | GO:0003847 | 1-alkyl-2-acetylglycerophosphocholine esterase activity(GO:0003847) |
0.9 | 6.6 | GO:0048273 | mitogen-activated protein kinase p38 binding(GO:0048273) |
0.9 | 36.4 | GO:0001784 | phosphotyrosine binding(GO:0001784) |
0.9 | 8.3 | GO:0043426 | MRF binding(GO:0043426) |
0.9 | 9.2 | GO:0015232 | heme transporter activity(GO:0015232) |
0.9 | 4.5 | GO:0017151 | DEAD/H-box RNA helicase binding(GO:0017151) |
0.9 | 9.6 | GO:0001206 | transcriptional repressor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001206) |
0.9 | 8.5 | GO:0003910 | DNA ligase (ATP) activity(GO:0003910) |
0.9 | 2.6 | GO:0004983 | neuropeptide Y receptor activity(GO:0004983) |
0.8 | 21.0 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
0.8 | 3.3 | GO:0030292 | protein tyrosine kinase inhibitor activity(GO:0030292) |
0.8 | 2.4 | GO:0010698 | acetyltransferase activator activity(GO:0010698) |
0.8 | 22.7 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
0.8 | 8.5 | GO:0004571 | mannosyl-oligosaccharide 1,2-alpha-mannosidase activity(GO:0004571) |
0.8 | 4.7 | GO:0008240 | tripeptidyl-peptidase activity(GO:0008240) peptidyl-dipeptidase activity(GO:0008241) |
0.8 | 10.1 | GO:0008429 | phosphatidylethanolamine binding(GO:0008429) |
0.8 | 5.4 | GO:0060072 | large conductance calcium-activated potassium channel activity(GO:0060072) |
0.8 | 10.5 | GO:0070679 | inositol 1,4,5 trisphosphate binding(GO:0070679) |
0.8 | 8.3 | GO:0004716 | receptor signaling protein tyrosine kinase activity(GO:0004716) |
0.7 | 14.4 | GO:0031418 | L-ascorbic acid binding(GO:0031418) |
0.7 | 5.8 | GO:1904315 | neurotransmitter receptor activity involved in regulation of postsynaptic membrane potential(GO:0099529) transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential(GO:1904315) |
0.7 | 2.2 | GO:0015189 | L-lysine transmembrane transporter activity(GO:0015189) |
0.7 | 2.2 | GO:0050613 | delta14-sterol reductase activity(GO:0050613) |
0.7 | 2.1 | GO:0022897 | peptide:proton symporter activity(GO:0015333) proton-dependent peptide secondary active transmembrane transporter activity(GO:0022897) |
0.7 | 12.7 | GO:0008510 | sodium:bicarbonate symporter activity(GO:0008510) |
0.7 | 2.1 | GO:0003845 | 11-beta-hydroxysteroid dehydrogenase [NAD(P)] activity(GO:0003845) |
0.7 | 8.2 | GO:0004017 | adenylate kinase activity(GO:0004017) |
0.7 | 72.7 | GO:0004867 | serine-type endopeptidase inhibitor activity(GO:0004867) |
0.7 | 5.3 | GO:0016929 | SUMO-specific protease activity(GO:0016929) |
0.6 | 2.6 | GO:0001591 | dopamine neurotransmitter receptor activity, coupled via Gi/Go(GO:0001591) |
0.6 | 3.2 | GO:0017169 | CDP-alcohol phosphatidyltransferase activity(GO:0017169) |
0.6 | 1.9 | GO:0070026 | cystathionine beta-synthase activity(GO:0004122) oxidoreductase activity, acting on other nitrogenous compounds as donors, cytochrome as acceptor(GO:0016662) nitrite reductase (NO-forming) activity(GO:0050421) carbon monoxide binding(GO:0070025) nitric oxide binding(GO:0070026) nitrite reductase activity(GO:0098809) |
0.6 | 8.1 | GO:0050998 | nitric-oxide synthase binding(GO:0050998) |
0.6 | 1.9 | GO:0043813 | phosphatidylinositol-3,5-bisphosphate 5-phosphatase activity(GO:0043813) |
0.6 | 8.5 | GO:0017049 | GTP-Rho binding(GO:0017049) |
0.6 | 5.3 | GO:0034483 | heparan sulfate sulfotransferase activity(GO:0034483) |
0.6 | 8.2 | GO:0050700 | CARD domain binding(GO:0050700) |
0.6 | 15.6 | GO:0005388 | calcium-transporting ATPase activity(GO:0005388) |
0.6 | 2.3 | GO:0004740 | pyruvate dehydrogenase (acetyl-transferring) kinase activity(GO:0004740) |
0.6 | 2.3 | GO:0022858 | L-alanine transmembrane transporter activity(GO:0015180) alanine transmembrane transporter activity(GO:0022858) |
0.6 | 3.9 | GO:0030020 | extracellular matrix structural constituent conferring tensile strength(GO:0030020) |
0.6 | 1.7 | GO:0017057 | 6-phosphogluconolactonase activity(GO:0017057) |
0.5 | 73.2 | GO:0003774 | motor activity(GO:0003774) |
0.5 | 38.9 | GO:0005089 | Rho guanyl-nucleotide exchange factor activity(GO:0005089) |
0.5 | 28.2 | GO:0048365 | Rac GTPase binding(GO:0048365) |
0.5 | 18.0 | GO:0005520 | insulin-like growth factor binding(GO:0005520) |
0.5 | 14.1 | GO:0005245 | voltage-gated calcium channel activity(GO:0005245) |
0.5 | 11.9 | GO:0005086 | ARF guanyl-nucleotide exchange factor activity(GO:0005086) |
0.5 | 10.3 | GO:0015269 | calcium-activated potassium channel activity(GO:0015269) |
0.5 | 6.0 | GO:0003906 | DNA-(apurinic or apyrimidinic site) lyase activity(GO:0003906) |
0.5 | 4.4 | GO:0031821 | G-protein coupled serotonin receptor binding(GO:0031821) |
0.5 | 3.0 | GO:0010997 | anaphase-promoting complex binding(GO:0010997) |
0.5 | 11.8 | GO:0043015 | gamma-tubulin binding(GO:0043015) |
0.5 | 0.5 | GO:0030551 | cyclic nucleotide binding(GO:0030551) |
0.5 | 2.4 | GO:0008048 | calcium sensitive guanylate cyclase activator activity(GO:0008048) |
0.5 | 55.8 | GO:0004222 | metalloendopeptidase activity(GO:0004222) |
0.5 | 4.9 | GO:0017147 | Wnt-protein binding(GO:0017147) |
0.5 | 23.4 | GO:0070412 | R-SMAD binding(GO:0070412) |
0.5 | 21.2 | GO:0030276 | clathrin binding(GO:0030276) |
0.5 | 6.7 | GO:0045499 | chemorepellent activity(GO:0045499) |
0.5 | 4.7 | GO:0004707 | MAP kinase activity(GO:0004707) |
0.5 | 1.4 | GO:0032422 | purine-rich negative regulatory element binding(GO:0032422) |
0.5 | 4.2 | GO:0005068 | transmembrane receptor protein tyrosine kinase adaptor activity(GO:0005068) |
0.5 | 0.9 | GO:0030158 | protein xylosyltransferase activity(GO:0030158) |
0.5 | 14.6 | GO:0005272 | sodium channel activity(GO:0005272) |
0.4 | 1.3 | GO:0004768 | stearoyl-CoA 9-desaturase activity(GO:0004768) acyl-CoA desaturase activity(GO:0016215) |
0.4 | 12.3 | GO:0003950 | NAD+ ADP-ribosyltransferase activity(GO:0003950) |
0.4 | 10.9 | GO:0004435 | phosphatidylinositol phospholipase C activity(GO:0004435) |
0.4 | 5.1 | GO:1904264 | ubiquitin protein ligase activity involved in ERAD pathway(GO:1904264) |
0.4 | 1.7 | GO:0005151 | interleukin-1, Type II receptor binding(GO:0005151) |
0.4 | 5.5 | GO:0016303 | 1-phosphatidylinositol-3-kinase activity(GO:0016303) |
0.4 | 1.7 | GO:0016230 | sphingomyelin phosphodiesterase activator activity(GO:0016230) |
0.4 | 1.2 | GO:0047150 | betaine-homocysteine S-methyltransferase activity(GO:0047150) |
0.4 | 3.3 | GO:0051864 | histone demethylase activity (H3-K36 specific)(GO:0051864) |
0.4 | 10.1 | GO:0032266 | phosphatidylinositol-3-phosphate binding(GO:0032266) |
0.4 | 2.4 | GO:0005025 | transforming growth factor beta receptor activity, type I(GO:0005025) |
0.4 | 8.4 | GO:0030275 | LRR domain binding(GO:0030275) |
0.4 | 4.0 | GO:0022821 | sodium:proton antiporter activity(GO:0015385) potassium:proton antiporter activity(GO:0015386) potassium ion antiporter activity(GO:0022821) |
0.4 | 4.3 | GO:0004931 | extracellular ATP-gated cation channel activity(GO:0004931) ATP-gated ion channel activity(GO:0035381) |
0.4 | 2.7 | GO:0071837 | HMG box domain binding(GO:0071837) |
0.4 | 5.0 | GO:0047372 | acylglycerol lipase activity(GO:0047372) |
0.4 | 4.2 | GO:0097016 | L27 domain binding(GO:0097016) |
0.4 | 7.1 | GO:0008392 | arachidonic acid monooxygenase activity(GO:0008391) arachidonic acid epoxygenase activity(GO:0008392) |
0.4 | 5.9 | GO:0033130 | acetylcholine receptor binding(GO:0033130) |
0.4 | 6.8 | GO:0017070 | U6 snRNA binding(GO:0017070) |
0.4 | 1.8 | GO:0046790 | virion binding(GO:0046790) |
0.3 | 1.7 | GO:0097108 | hedgehog family protein binding(GO:0097108) |
0.3 | 1.7 | GO:0046592 | polyamine oxidase activity(GO:0046592) spermine:oxygen oxidoreductase (spermidine-forming) activity(GO:0052901) |
0.3 | 2.9 | GO:0004969 | histamine receptor activity(GO:0004969) |
0.3 | 8.0 | GO:0005523 | tropomyosin binding(GO:0005523) |
0.3 | 6.3 | GO:0031489 | myosin V binding(GO:0031489) |
0.3 | 2.5 | GO:0097322 | 7SK snRNA binding(GO:0097322) |
0.3 | 52.8 | GO:0005088 | Ras guanyl-nucleotide exchange factor activity(GO:0005088) |
0.3 | 3.6 | GO:0004691 | cAMP-dependent protein kinase activity(GO:0004691) |
0.3 | 2.6 | GO:0086083 | cell adhesive protein binding involved in bundle of His cell-Purkinje myocyte communication(GO:0086083) |
0.3 | 2.3 | GO:0003876 | AMP deaminase activity(GO:0003876) adenosine-phosphate deaminase activity(GO:0047623) |
0.3 | 2.0 | GO:0097109 | neuroligin family protein binding(GO:0097109) |
0.3 | 3.0 | GO:0016594 | glycine binding(GO:0016594) |
0.3 | 5.6 | GO:0032452 | histone demethylase activity(GO:0032452) |
0.3 | 8.2 | GO:0035035 | histone acetyltransferase binding(GO:0035035) |
0.3 | 5.8 | GO:0016805 | dipeptidase activity(GO:0016805) |
0.3 | 5.7 | GO:0005247 | voltage-gated chloride channel activity(GO:0005247) |
0.3 | 28.0 | GO:0003707 | steroid hormone receptor activity(GO:0003707) |
0.3 | 3.6 | GO:0015095 | magnesium ion transmembrane transporter activity(GO:0015095) |
0.2 | 4.7 | GO:0051371 | muscle alpha-actinin binding(GO:0051371) |
0.2 | 2.7 | GO:0003996 | acyl-CoA ligase activity(GO:0003996) |
0.2 | 13.2 | GO:0005262 | calcium channel activity(GO:0005262) |
0.2 | 8.5 | GO:0001205 | transcriptional activator activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001205) |
0.2 | 0.7 | GO:0004574 | oligo-1,6-glucosidase activity(GO:0004574) |
0.2 | 0.7 | GO:0042799 | histone methyltransferase activity (H4-K20 specific)(GO:0042799) |
0.2 | 7.7 | GO:0004712 | protein serine/threonine/tyrosine kinase activity(GO:0004712) |
0.2 | 133.3 | GO:0005509 | calcium ion binding(GO:0005509) |
0.2 | 2.6 | GO:0043395 | heparan sulfate proteoglycan binding(GO:0043395) |
0.2 | 3.0 | GO:0005243 | gap junction channel activity(GO:0005243) |
0.2 | 2.9 | GO:0031957 | very long-chain fatty acid-CoA ligase activity(GO:0031957) |
0.2 | 12.7 | GO:0048306 | calcium-dependent protein binding(GO:0048306) |
0.2 | 7.5 | GO:0030544 | Hsp70 protein binding(GO:0030544) |
0.2 | 6.6 | GO:0030291 | protein serine/threonine kinase inhibitor activity(GO:0030291) |
0.2 | 1.6 | GO:0019955 | cytokine binding(GO:0019955) |
0.2 | 10.0 | GO:0008028 | monocarboxylic acid transmembrane transporter activity(GO:0008028) |
0.2 | 8.5 | GO:0008013 | beta-catenin binding(GO:0008013) |
0.2 | 3.0 | GO:0004535 | poly(A)-specific ribonuclease activity(GO:0004535) |
0.2 | 1.3 | GO:0004996 | thyroid-stimulating hormone receptor activity(GO:0004996) |
0.2 | 9.2 | GO:0004869 | cysteine-type endopeptidase inhibitor activity(GO:0004869) |
0.2 | 5.3 | GO:0005031 | tumor necrosis factor-activated receptor activity(GO:0005031) death receptor activity(GO:0005035) |
0.2 | 7.0 | GO:0017080 | sodium channel regulator activity(GO:0017080) |
0.2 | 2.6 | GO:0070016 | armadillo repeat domain binding(GO:0070016) |
0.2 | 2.2 | GO:0019707 | protein-cysteine S-palmitoyltransferase activity(GO:0019706) protein-cysteine S-acyltransferase activity(GO:0019707) |
0.2 | 19.4 | GO:0017137 | Rab GTPase binding(GO:0017137) |
0.2 | 0.5 | GO:0030023 | extracellular matrix constituent conferring elasticity(GO:0030023) |
0.1 | 2.5 | GO:0050811 | GABA receptor binding(GO:0050811) |
0.1 | 4.1 | GO:0017091 | AU-rich element binding(GO:0017091) |
0.1 | 1.4 | GO:0016004 | phospholipase activator activity(GO:0016004) |
0.1 | 3.7 | GO:0030371 | translation repressor activity(GO:0030371) |
0.1 | 1.5 | GO:0032183 | SUMO binding(GO:0032183) |
0.1 | 0.5 | GO:0004102 | choline O-acetyltransferase activity(GO:0004102) |
0.1 | 1.1 | GO:0000150 | recombinase activity(GO:0000150) |
0.1 | 18.1 | GO:0008017 | microtubule binding(GO:0008017) |
0.1 | 2.7 | GO:0005109 | frizzled binding(GO:0005109) |
0.1 | 29.3 | GO:0003924 | GTPase activity(GO:0003924) |
0.1 | 1.0 | GO:0045125 | bioactive lipid receptor activity(GO:0045125) |
0.1 | 1.4 | GO:0070742 | C2H2 zinc finger domain binding(GO:0070742) |
0.1 | 3.2 | GO:0016859 | cis-trans isomerase activity(GO:0016859) |
0.1 | 23.3 | GO:0001077 | transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0001077) |
0.1 | 0.5 | GO:0016670 | oxidoreductase activity, acting on a sulfur group of donors, oxygen as acceptor(GO:0016670) |
0.1 | 0.3 | GO:0052844 | endopolyphosphatase activity(GO:0000298) diphosphoinositol-polyphosphate diphosphatase activity(GO:0008486) bis(5'-adenosyl)-hexaphosphatase activity(GO:0034431) bis(5'-adenosyl)-pentaphosphatase activity(GO:0034432) inositol diphosphate tetrakisphosphate diphosphatase activity(GO:0052840) inositol bisdiphosphate tetrakisphosphate diphosphatase activity(GO:0052841) inositol diphosphate pentakisphosphate diphosphatase activity(GO:0052842) inositol-1-diphosphate-2,3,4,5,6-pentakisphosphate diphosphatase activity(GO:0052843) inositol-3-diphosphate-1,2,4,5,6-pentakisphosphate diphosphatase activity(GO:0052844) inositol-5-diphosphate-1,2,3,4,6-pentakisphosphate diphosphatase activity(GO:0052845) inositol-1,5-bisdiphosphate-2,3,4,6-tetrakisphosphate 1-diphosphatase activity(GO:0052846) inositol-1,5-bisdiphosphate-2,3,4,6-tetrakisphosphate 5-diphosphatase activity(GO:0052847) inositol-3,5-bisdiphosphate-2,3,4,6-tetrakisphosphate 5-diphosphatase activity(GO:0052848) |
0.1 | 0.2 | GO:0086089 | voltage-gated potassium channel activity involved in atrial cardiac muscle cell action potential repolarization(GO:0086089) |
0.1 | 4.1 | GO:0005319 | lipid transporter activity(GO:0005319) |
0.1 | 1.4 | GO:0005158 | insulin receptor binding(GO:0005158) |
0.1 | 0.6 | GO:0008190 | eukaryotic initiation factor 4E binding(GO:0008190) |
0.1 | 0.4 | GO:0017077 | oxidative phosphorylation uncoupler activity(GO:0017077) |
0.1 | 4.3 | GO:0022843 | voltage-gated cation channel activity(GO:0022843) |
0.1 | 27.3 | GO:0000981 | RNA polymerase II transcription factor activity, sequence-specific DNA binding(GO:0000981) |
0.1 | 0.6 | GO:0030215 | semaphorin receptor binding(GO:0030215) |
0.1 | 0.2 | GO:0015222 | serotonin transmembrane transporter activity(GO:0015222) |
0.0 | 2.6 | GO:1901981 | phosphatidylinositol phosphate binding(GO:1901981) |
0.0 | 12.2 | GO:0008236 | serine-type peptidase activity(GO:0008236) |
0.0 | 5.1 | GO:0005179 | hormone activity(GO:0005179) |
0.0 | 0.5 | GO:0035325 | Toll-like receptor binding(GO:0035325) |
0.0 | 0.4 | GO:0017176 | phosphatidylinositol N-acetylglucosaminyltransferase activity(GO:0017176) |
0.0 | 0.2 | GO:0004873 | asialoglycoprotein receptor activity(GO:0004873) |
0.0 | 1.7 | GO:0001085 | RNA polymerase II transcription factor binding(GO:0001085) |
0.0 | 0.3 | GO:0051378 | amine binding(GO:0043176) serotonin binding(GO:0051378) |
0.0 | 1.2 | GO:0005085 | guanyl-nucleotide exchange factor activity(GO:0005085) |
0.0 | 0.3 | GO:0008237 | metallopeptidase activity(GO:0008237) |
0.0 | 0.4 | GO:0005044 | scavenger receptor activity(GO:0005044) |
0.0 | 0.8 | GO:0001540 | beta-amyloid binding(GO:0001540) |
0.0 | 0.7 | GO:0004402 | histone acetyltransferase activity(GO:0004402) |
0.0 | 0.4 | GO:0030170 | pyridoxal phosphate binding(GO:0030170) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
3.0 | 29.6 | PID A6B1 A6B4 INTEGRIN PATHWAY | a6b1 and a6b4 Integrin signaling |
2.0 | 71.4 | ST WNT CA2 CYCLIC GMP PATHWAY | Wnt/Ca2+/cyclic GMP signaling. |
1.5 | 10.6 | PID INTEGRIN1 PATHWAY | Beta1 integrin cell surface interactions |
1.5 | 28.6 | PID ALK2 PATHWAY | ALK2 signaling events |
1.5 | 26.3 | PID TCR RAS PATHWAY | Ras signaling in the CD4+ TCR pathway |
1.4 | 4.3 | PID NFAT 3PATHWAY | Role of Calcineurin-dependent NFAT signaling in lymphocytes |
1.4 | 60.7 | ST WNT BETA CATENIN PATHWAY | Wnt/beta-catenin Pathway |
1.4 | 34.2 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
1.3 | 10.5 | PID HDAC CLASSIII PATHWAY | Signaling events mediated by HDAC Class III |
1.1 | 13.6 | PID GLYPICAN 1PATHWAY | Glypican 1 network |
1.1 | 45.9 | PID NCADHERIN PATHWAY | N-cadherin signaling events |
1.1 | 24.0 | SA B CELL RECEPTOR COMPLEXES | Antigen binding to B cell receptors activates protein tyrosine kinases, such as the Src family, which ultimate activate MAP kinases. |
1.1 | 92.3 | PID ERBB1 INTERNALIZATION PATHWAY | Internalization of ErbB1 |
1.0 | 4.1 | PID ECADHERIN KERATINOCYTE PATHWAY | E-cadherin signaling in keratinocytes |
1.0 | 42.5 | PID LIS1 PATHWAY | Lissencephaly gene (LIS1) in neuronal migration and development |
1.0 | 52.2 | ST JNK MAPK PATHWAY | JNK MAPK Pathway |
0.9 | 9.2 | PID INTEGRIN A4B1 PATHWAY | Alpha4 beta1 integrin signaling events |
0.9 | 14.5 | ST GA12 PATHWAY | G alpha 12 Pathway |
0.9 | 50.0 | PID AJDISS 2PATHWAY | Posttranslational regulation of adherens junction stability and dissassembly |
0.8 | 33.5 | PID TCR CALCIUM PATHWAY | Calcium signaling in the CD4+ TCR pathway |
0.7 | 34.0 | PID RAC1 REG PATHWAY | Regulation of RAC1 activity |
0.7 | 7.4 | PID PI3K PLC TRK PATHWAY | Trk receptor signaling mediated by PI3K and PLC-gamma |
0.7 | 13.2 | PID RET PATHWAY | Signaling events regulated by Ret tyrosine kinase |
0.7 | 59.7 | ST INTEGRIN SIGNALING PATHWAY | Integrin Signaling Pathway |
0.7 | 3.3 | NABA BASEMENT MEMBRANES | Genes encoding structural components of basement membranes |
0.6 | 19.9 | PID S1P S1P3 PATHWAY | S1P3 pathway |
0.6 | 158.3 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
0.6 | 34.2 | PID RHOA REG PATHWAY | Regulation of RhoA activity |
0.6 | 9.2 | PID ATR PATHWAY | ATR signaling pathway |
0.6 | 132.5 | NABA ECM GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
0.5 | 7.2 | PID NECTIN PATHWAY | Nectin adhesion pathway |
0.5 | 9.0 | PID BETA CATENIN NUC PATHWAY | Regulation of nuclear beta catenin signaling and target gene transcription |
0.5 | 6.1 | PID ARF6 DOWNSTREAM PATHWAY | Arf6 downstream pathway |
0.5 | 17.2 | PID HIF2PATHWAY | HIF-2-alpha transcription factor network |
0.5 | 20.0 | PID FGF PATHWAY | FGF signaling pathway |
0.5 | 4.5 | PID ALK1 PATHWAY | ALK1 signaling events |
0.4 | 19.8 | PID ARF6 PATHWAY | Arf6 signaling events |
0.4 | 7.9 | PID VEGFR1 PATHWAY | VEGFR1 specific signals |
0.4 | 3.9 | PID EPHB FWD PATHWAY | EPHB forward signaling |
0.4 | 25.2 | PID AVB3 INTEGRIN PATHWAY | Integrins in angiogenesis |
0.4 | 29.9 | PID TAP63 PATHWAY | Validated transcriptional targets of TAp63 isoforms |
0.4 | 9.6 | SIG PIP3 SIGNALING IN B LYMPHOCYTES | Genes related to PIP3 signaling in B lymphocytes |
0.4 | 14.5 | PID ECADHERIN STABILIZATION PATHWAY | Stabilization and expansion of the E-cadherin adherens junction |
0.4 | 22.7 | NABA PROTEOGLYCANS | Genes encoding proteoglycans |
0.4 | 6.6 | ST ADRENERGIC | Adrenergic Pathway |
0.3 | 8.9 | PID EPHA FWDPATHWAY | EPHA forward signaling |
0.3 | 8.0 | PID CIRCADIAN PATHWAY | Circadian rhythm pathway |
0.3 | 6.0 | PID CERAMIDE PATHWAY | Ceramide signaling pathway |
0.3 | 6.6 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
0.3 | 3.0 | SIG IL4RECEPTOR IN B LYPHOCYTES | Genes related to IL4 rceptor signaling in B lymphocytes |
0.2 | 23.2 | PID P73PATHWAY | p73 transcription factor network |
0.2 | 7.4 | PID SHP2 PATHWAY | SHP2 signaling |
0.2 | 4.7 | SA MMP CYTOKINE CONNECTION | Cytokines can induce activation of matrix metalloproteinases, which degrade extracellular matrix. |
0.2 | 3.8 | PID ERBB1 DOWNSTREAM PATHWAY | ErbB1 downstream signaling |
0.2 | 2.6 | ST G ALPHA I PATHWAY | G alpha i Pathway |
0.2 | 5.9 | PID ALPHA SYNUCLEIN PATHWAY | Alpha-synuclein signaling |
0.2 | 3.6 | PID ARF6 TRAFFICKING PATHWAY | Arf6 trafficking events |
0.2 | 12.0 | ST FAS SIGNALING PATHWAY | Fas Signaling Pathway |
0.2 | 5.0 | PID MTOR 4PATHWAY | mTOR signaling pathway |
0.2 | 2.6 | PID FRA PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
0.2 | 2.4 | PID INTEGRIN5 PATHWAY | Beta5 beta6 beta7 and beta8 integrin cell surface interactions |
0.2 | 1.7 | PID INTEGRIN A9B1 PATHWAY | Alpha9 beta1 integrin signaling events |
0.1 | 9.8 | PID HIF1 TFPATHWAY | HIF-1-alpha transcription factor network |
0.1 | 2.4 | PID ENDOTHELIN PATHWAY | Endothelins |
0.1 | 3.5 | PID RAS PATHWAY | Regulation of Ras family activation |
0.1 | 3.3 | PID TRKR PATHWAY | Neurotrophic factor-mediated Trk receptor signaling |
0.1 | 0.5 | PID THROMBIN PAR1 PATHWAY | PAR1-mediated thrombin signaling events |
0.1 | 0.6 | PID AR NONGENOMIC PATHWAY | Nongenotropic Androgen signaling |
0.1 | 4.0 | PID CXCR4 PATHWAY | CXCR4-mediated signaling events |
0.1 | 1.6 | PID P38 GAMMA DELTA PATHWAY | Signaling mediated by p38-gamma and p38-delta |
0.1 | 3.8 | PID FOXM1 PATHWAY | FOXM1 transcription factor network |
0.1 | 1.7 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
0.1 | 2.0 | PID AURORA A PATHWAY | Aurora A signaling |
0.1 | 3.7 | PID HDAC CLASSI PATHWAY | Signaling events mediated by HDAC Class I |
0.1 | 2.3 | PID HEDGEHOG GLI PATHWAY | Hedgehog signaling events mediated by Gli proteins |
0.0 | 1.6 | PID RAC1 PATHWAY | RAC1 signaling pathway |
0.0 | 0.9 | PID INTEGRIN2 PATHWAY | Beta2 integrin cell surface interactions |
0.0 | 0.4 | PID NETRIN PATHWAY | Netrin-mediated signaling events |
0.0 | 4.6 | NABA SECRETED FACTORS | Genes encoding secreted soluble factors |
0.0 | 0.1 | PID ERB GENOMIC PATHWAY | Validated nuclear estrogen receptor beta network |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
3.6 | 100.1 | REACTOME CRMPS IN SEMA3A SIGNALING | Genes involved in CRMPs in Sema3A signaling |
2.7 | 13.6 | REACTOME FGFR2C LIGAND BINDING AND ACTIVATION | Genes involved in FGFR2c ligand binding and activation |
2.7 | 90.8 | REACTOME INTERACTION BETWEEN L1 AND ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |
2.5 | 45.7 | REACTOME DOPAMINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Dopamine Neurotransmitter Release Cycle |
2.5 | 7.5 | REACTOME SYNTHESIS SECRETION AND DEACYLATION OF GHRELIN | Genes involved in Synthesis, Secretion, and Deacylation of Ghrelin |
2.5 | 44.4 | REACTOME CLASS C 3 METABOTROPIC GLUTAMATE PHEROMONE RECEPTORS | Genes involved in Class C/3 (Metabotropic glutamate/pheromone receptors) |
2.4 | 28.9 | REACTOME ADENYLATE CYCLASE ACTIVATING PATHWAY | Genes involved in Adenylate cyclase activating pathway |
2.3 | 48.8 | REACTOME SIGNAL ATTENUATION | Genes involved in Signal attenuation |
2.1 | 53.7 | REACTOME CREB PHOSPHORYLATION THROUGH THE ACTIVATION OF CAMKII | Genes involved in CREB phosphorylation through the activation of CaMKII |
1.7 | 64.0 | REACTOME EGFR DOWNREGULATION | Genes involved in EGFR downregulation |
1.7 | 45.0 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
1.6 | 32.5 | REACTOME ABCA TRANSPORTERS IN LIPID HOMEOSTASIS | Genes involved in ABCA transporters in lipid homeostasis |
1.5 | 39.9 | REACTOME DCC MEDIATED ATTRACTIVE SIGNALING | Genes involved in DCC mediated attractive signaling |
1.4 | 7.2 | REACTOME SEMA3A PLEXIN REPULSION SIGNALING BY INHIBITING INTEGRIN ADHESION | Genes involved in SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion |
1.4 | 26.7 | REACTOME PKA MEDIATED PHOSPHORYLATION OF CREB | Genes involved in PKA-mediated phosphorylation of CREB |
1.4 | 18.2 | REACTOME SIGNALING BY FGFR3 MUTANTS | Genes involved in Signaling by FGFR3 mutants |
1.4 | 31.9 | REACTOME PRE NOTCH PROCESSING IN GOLGI | Genes involved in Pre-NOTCH Processing in Golgi |
1.3 | 50.6 | REACTOME A TETRASACCHARIDE LINKER SEQUENCE IS REQUIRED FOR GAG SYNTHESIS | Genes involved in A tetrasaccharide linker sequence is required for GAG synthesis |
1.2 | 22.5 | REACTOME IONOTROPIC ACTIVITY OF KAINATE RECEPTORS | Genes involved in Ionotropic activity of Kainate Receptors |
1.2 | 49.7 | REACTOME SIGNALING BY ROBO RECEPTOR | Genes involved in Signaling by Robo receptor |
1.2 | 22.7 | REACTOME TRAFFICKING OF GLUR2 CONTAINING AMPA RECEPTORS | Genes involved in Trafficking of GluR2-containing AMPA receptors |
1.2 | 14.0 | REACTOME GLUTAMATE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Glutamate Neurotransmitter Release Cycle |
1.2 | 55.7 | REACTOME ION TRANSPORT BY P TYPE ATPASES | Genes involved in Ion transport by P-type ATPases |
1.1 | 12.1 | REACTOME ROLE OF SECOND MESSENGERS IN NETRIN1 SIGNALING | Genes involved in Role of second messengers in netrin-1 signaling |
1.1 | 7.6 | REACTOME TANDEM PORE DOMAIN POTASSIUM CHANNELS | Genes involved in Tandem pore domain potassium channels |
1.1 | 41.3 | REACTOME SULFUR AMINO ACID METABOLISM | Genes involved in Sulfur amino acid metabolism |
1.0 | 7.3 | REACTOME SIGNALING BY EGFR IN CANCER | Genes involved in Signaling by EGFR in Cancer |
1.0 | 12.8 | REACTOME ANDROGEN BIOSYNTHESIS | Genes involved in Androgen biosynthesis |
1.0 | 23.4 | REACTOME AMINE DERIVED HORMONES | Genes involved in Amine-derived hormones |
1.0 | 6.8 | REACTOME ACYL CHAIN REMODELLING OF PE | Genes involved in Acyl chain remodelling of PE |
1.0 | 16.3 | REACTOME REGULATION OF PYRUVATE DEHYDROGENASE PDH COMPLEX | Genes involved in Regulation of pyruvate dehydrogenase (PDH) complex |
0.9 | 15.8 | REACTOME THROMBIN SIGNALLING THROUGH PROTEINASE ACTIVATED RECEPTORS PARS | Genes involved in Thrombin signalling through proteinase activated receptors (PARs) |
0.8 | 16.7 | REACTOME INITIAL TRIGGERING OF COMPLEMENT | Genes involved in Initial triggering of complement |
0.8 | 15.5 | REACTOME HS GAG BIOSYNTHESIS | Genes involved in HS-GAG biosynthesis |
0.7 | 20.2 | REACTOME OXYGEN DEPENDENT PROLINE HYDROXYLATION OF HYPOXIA INDUCIBLE FACTOR ALPHA | Genes involved in Oxygen-dependent Proline Hydroxylation of Hypoxia-inducible Factor Alpha |
0.7 | 29.7 | REACTOME SYNTHESIS OF PIPS AT THE PLASMA MEMBRANE | Genes involved in Synthesis of PIPs at the plasma membrane |
0.7 | 13.8 | REACTOME INTRINSIC PATHWAY | Genes involved in Intrinsic Pathway |
0.7 | 15.0 | REACTOME SYNTHESIS OF PIPS AT THE GOLGI MEMBRANE | Genes involved in Synthesis of PIPs at the Golgi membrane |
0.7 | 17.9 | REACTOME RECYCLING PATHWAY OF L1 | Genes involved in Recycling pathway of L1 |
0.7 | 29.3 | REACTOME ELONGATION ARREST AND RECOVERY | Genes involved in Elongation arrest and recovery |
0.7 | 26.2 | REACTOME CGMP EFFECTS | Genes involved in cGMP effects |
0.6 | 20.3 | REACTOME DEGRADATION OF THE EXTRACELLULAR MATRIX | Genes involved in Degradation of the extracellular matrix |
0.6 | 9.1 | REACTOME NITRIC OXIDE STIMULATES GUANYLATE CYCLASE | Genes involved in Nitric oxide stimulates guanylate cyclase |
0.6 | 30.6 | REACTOME BMAL1 CLOCK NPAS2 ACTIVATES CIRCADIAN EXPRESSION | Genes involved in BMAL1:CLOCK/NPAS2 Activates Circadian Expression |
0.6 | 7.5 | REACTOME SIGNALING BY HIPPO | Genes involved in Signaling by Hippo |
0.6 | 5.1 | REACTOME REGULATION OF HYPOXIA INDUCIBLE FACTOR HIF BY OXYGEN | Genes involved in Regulation of Hypoxia-inducible Factor (HIF) by Oxygen |
0.6 | 11.3 | REACTOME GABA SYNTHESIS RELEASE REUPTAKE AND DEGRADATION | Genes involved in GABA synthesis, release, reuptake and degradation |
0.5 | 15.7 | REACTOME SIGNALING BY NODAL | Genes involved in Signaling by NODAL |
0.5 | 10.1 | REACTOME REGULATION OF INSULIN SECRETION BY GLUCAGON LIKE PEPTIDE1 | Genes involved in Regulation of Insulin Secretion by Glucagon-like Peptide-1 |
0.5 | 15.4 | REACTOME DARPP 32 EVENTS | Genes involved in DARPP-32 events |
0.5 | 6.6 | REACTOME HORMONE LIGAND BINDING RECEPTORS | Genes involved in Hormone ligand-binding receptors |
0.5 | 6.4 | REACTOME REGULATION OF WATER BALANCE BY RENAL AQUAPORINS | Genes involved in Regulation of Water Balance by Renal Aquaporins |
0.5 | 9.4 | REACTOME AKT PHOSPHORYLATES TARGETS IN THE CYTOSOL | Genes involved in AKT phosphorylates targets in the cytosol |
0.5 | 12.7 | REACTOME ENERGY DEPENDENT REGULATION OF MTOR BY LKB1 AMPK | Genes involved in Energy dependent regulation of mTOR by LKB1-AMPK |
0.5 | 8.6 | REACTOME ACYL CHAIN REMODELLING OF PI | Genes involved in Acyl chain remodelling of PI |
0.4 | 6.7 | REACTOME BILE SALT AND ORGANIC ANION SLC TRANSPORTERS | Genes involved in Bile salt and organic anion SLC transporters |
0.4 | 2.7 | REACTOME IRAK2 MEDIATED ACTIVATION OF TAK1 COMPLEX UPON TLR7 8 OR 9 STIMULATION | Genes involved in IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation |
0.4 | 15.6 | REACTOME GPVI MEDIATED ACTIVATION CASCADE | Genes involved in GPVI-mediated activation cascade |
0.4 | 19.4 | REACTOME CLASS B 2 SECRETIN FAMILY RECEPTORS | Genes involved in Class B/2 (Secretin family receptors) |
0.4 | 4.7 | REACTOME DSCAM INTERACTIONS | Genes involved in DSCAM interactions |
0.4 | 18.6 | REACTOME VOLTAGE GATED POTASSIUM CHANNELS | Genes involved in Voltage gated Potassium channels |
0.4 | 12.9 | REACTOME PEROXISOMAL LIPID METABOLISM | Genes involved in Peroxisomal lipid metabolism |
0.4 | 83.3 | REACTOME G ALPHA I SIGNALLING EVENTS | Genes involved in G alpha (i) signalling events |
0.4 | 12.5 | REACTOME EFFECTS OF PIP2 HYDROLYSIS | Genes involved in Effects of PIP2 hydrolysis |
0.4 | 21.9 | REACTOME NCAM1 INTERACTIONS | Genes involved in NCAM1 interactions |
0.3 | 8.2 | REACTOME ACTIVATED NOTCH1 TRANSMITS SIGNAL TO THE NUCLEUS | Genes involved in Activated NOTCH1 Transmits Signal to the Nucleus |
0.3 | 10.6 | REACTOME POTASSIUM CHANNELS | Genes involved in Potassium Channels |
0.3 | 5.6 | REACTOME SYNTHESIS OF PA | Genes involved in Synthesis of PA |
0.3 | 5.6 | REACTOME MITOCHONDRIAL FATTY ACID BETA OXIDATION | Genes involved in Mitochondrial Fatty Acid Beta-Oxidation |
0.3 | 4.6 | REACTOME CALNEXIN CALRETICULIN CYCLE | Genes involved in Calnexin/calreticulin cycle |
0.3 | 6.3 | REACTOME YAP1 AND WWTR1 TAZ STIMULATED GENE EXPRESSION | Genes involved in YAP1- and WWTR1 (TAZ)-stimulated gene expression |
0.3 | 11.0 | REACTOME NEGATIVE REGULATORS OF RIG I MDA5 SIGNALING | Genes involved in Negative regulators of RIG-I/MDA5 signaling |
0.3 | 4.1 | REACTOME TRYPTOPHAN CATABOLISM | Genes involved in Tryptophan catabolism |
0.3 | 1.7 | REACTOME ANTIGEN PRESENTATION FOLDING ASSEMBLY AND PEPTIDE LOADING OF CLASS I MHC | Genes involved in Antigen Presentation: Folding, assembly and peptide loading of class I MHC |
0.3 | 2.4 | REACTOME GAP JUNCTION DEGRADATION | Genes involved in Gap junction degradation |
0.3 | 8.1 | REACTOME GLUTATHIONE CONJUGATION | Genes involved in Glutathione conjugation |
0.3 | 31.2 | REACTOME MHC CLASS II ANTIGEN PRESENTATION | Genes involved in MHC class II antigen presentation |
0.2 | 9.3 | REACTOME TIGHT JUNCTION INTERACTIONS | Genes involved in Tight junction interactions |
0.2 | 4.6 | REACTOME SYNTHESIS OF PE | Genes involved in Synthesis of PE |
0.2 | 18.8 | REACTOME G ALPHA S SIGNALLING EVENTS | Genes involved in G alpha (s) signalling events |
0.2 | 36.6 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |
0.2 | 7.7 | REACTOME PTM GAMMA CARBOXYLATION HYPUSINE FORMATION AND ARYLSULFATASE ACTIVATION | Genes involved in PTM: gamma carboxylation, hypusine formation and arylsulfatase activation |
0.2 | 2.6 | REACTOME ACTIVATION OF CHAPERONE GENES BY ATF6 ALPHA | Genes involved in Activation of Chaperone Genes by ATF6-alpha |
0.2 | 5.2 | REACTOME CELL EXTRACELLULAR MATRIX INTERACTIONS | Genes involved in Cell-extracellular matrix interactions |
0.2 | 15.8 | REACTOME INTERFERON GAMMA SIGNALING | Genes involved in Interferon gamma signaling |
0.2 | 4.0 | REACTOME RESOLUTION OF AP SITES VIA THE SINGLE NUCLEOTIDE REPLACEMENT PATHWAY | Genes involved in Resolution of AP sites via the single-nucleotide replacement pathway |
0.2 | 3.7 | REACTOME N GLYCAN ANTENNAE ELONGATION IN THE MEDIAL TRANS GOLGI | Genes involved in N-glycan antennae elongation in the medial/trans-Golgi |
0.2 | 20.4 | REACTOME TRANSPORT OF INORGANIC CATIONS ANIONS AND AMINO ACIDS OLIGOPEPTIDES | Genes involved in Transport of inorganic cations/anions and amino acids/oligopeptides |
0.2 | 3.0 | REACTOME GAP JUNCTION ASSEMBLY | Genes involved in Gap junction assembly |
0.2 | 4.5 | REACTOME KERATAN SULFATE BIOSYNTHESIS | Genes involved in Keratan sulfate biosynthesis |
0.2 | 10.8 | REACTOME METABOLISM OF VITAMINS AND COFACTORS | Genes involved in Metabolism of vitamins and cofactors |
0.2 | 1.1 | REACTOME NOTCH HLH TRANSCRIPTION PATHWAY | Genes involved in Notch-HLH transcription pathway |
0.1 | 3.2 | REACTOME GAB1 SIGNALOSOME | Genes involved in GAB1 signalosome |
0.1 | 2.2 | REACTOME RECRUITMENT OF NUMA TO MITOTIC CENTROSOMES | Genes involved in Recruitment of NuMA to mitotic centrosomes |
0.1 | 9.8 | REACTOME NUCLEAR RECEPTOR TRANSCRIPTION PATHWAY | Genes involved in Nuclear Receptor transcription pathway |
0.1 | 6.9 | REACTOME CYTOCHROME P450 ARRANGED BY SUBSTRATE TYPE | Genes involved in Cytochrome P450 - arranged by substrate type |
0.1 | 3.6 | REACTOME CELL CELL JUNCTION ORGANIZATION | Genes involved in Cell-cell junction organization |
0.1 | 2.7 | REACTOME REGULATION OF BETA CELL DEVELOPMENT | Genes involved in Regulation of beta-cell development |
0.1 | 2.8 | REACTOME CHOLESTEROL BIOSYNTHESIS | Genes involved in Cholesterol biosynthesis |
0.1 | 2.3 | REACTOME PURINE SALVAGE | Genes involved in Purine salvage |
0.1 | 4.3 | REACTOME IRON UPTAKE AND TRANSPORT | Genes involved in Iron uptake and transport |
0.1 | 1.6 | REACTOME HIGHLY CALCIUM PERMEABLE POSTSYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | Genes involved in Highly calcium permeable postsynaptic nicotinic acetylcholine receptors |
0.1 | 2.1 | REACTOME HOMOLOGOUS RECOMBINATION REPAIR OF REPLICATION INDEPENDENT DOUBLE STRAND BREAKS | Genes involved in Homologous recombination repair of replication-independent double-strand breaks |
0.1 | 0.5 | REACTOME ACETYLCHOLINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Acetylcholine Neurotransmitter Release Cycle |
0.1 | 0.5 | REACTOME TRAFFICKING AND PROCESSING OF ENDOSOMAL TLR | Genes involved in Trafficking and processing of endosomal TLR |
0.1 | 1.7 | REACTOME PHASE1 FUNCTIONALIZATION OF COMPOUNDS | Genes involved in Phase 1 - Functionalization of compounds |
0.1 | 4.8 | REACTOME INTEGRIN CELL SURFACE INTERACTIONS | Genes involved in Integrin cell surface interactions |
0.1 | 1.3 | REACTOME SIGNALING BY BMP | Genes involved in Signaling by BMP |
0.1 | 1.9 | REACTOME RNA POL I TRANSCRIPTION INITIATION | Genes involved in RNA Polymerase I Transcription Initiation |
0.0 | 0.6 | REACTOME PKB MEDIATED EVENTS | Genes involved in PKB-mediated events |
0.0 | 2.4 | REACTOME AMYLOIDS | Genes involved in Amyloids |
0.0 | 0.6 | REACTOME ORGANIC CATION ANION ZWITTERION TRANSPORT | Genes involved in Organic cation/anion/zwitterion transport |
0.0 | 0.4 | REACTOME SYNTHESIS OF GLYCOSYLPHOSPHATIDYLINOSITOL GPI | Genes involved in Synthesis of glycosylphosphatidylinositol (GPI) |
0.0 | 0.3 | REACTOME POST CHAPERONIN TUBULIN FOLDING PATHWAY | Genes involved in Post-chaperonin tubulin folding pathway |
0.0 | 0.2 | REACTOME IL RECEPTOR SHC SIGNALING | Genes involved in Interleukin receptor SHC signaling |